BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 757054 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2c(Cl)ccc(C)c2F)c2ccccc12 InChI=1S/C25H20ClFN6O/c1-15-7-8-19(26)18(22(15)27)14-33-20-6-4-3-5-17(20)23(32-33)25-29-13-21(34-2)24(31-25)30-16-9-11-28-12-10-16/h3-13H,14H2,1-2H3,(H,28,29,30,31) UCOFWWYBTJWSPL-UHFFFAOYSA-N 378915 2-[1-(6-chloro-2-fluoro-3-methylbenzyl)-1H-indazol-3-yl]-5-methoxy-N-(pyridin-4-yl)pyrimidin-4-amine::US10266548, Example 2-1-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 2.60 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378915 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378915&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71554399 404338909 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757055 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2cccc(c2)-n2cccc2)c2ccccc12 InChI=1S/C28H23N7O/c1-36-25-18-30-28(32-27(25)31-21-11-13-29-14-12-21)26-23-9-2-3-10-24(23)35(33-26)19-20-7-6-8-22(17-20)34-15-4-5-16-34/h2-18H,19H2,1H3,(H,29,30,31,32) SMJMAUGPGKDXRF-UHFFFAOYSA-N 378916 5-methoxy-N- (pyridin-4-yl)- 2-{1-[3-(1H- pyrrol-1- yl)benzyl]-1H- indazol-3- yl}pyrimidin-4- amine::US10266548, Example 2-1-3 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 120 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378916 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378916&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71554142 404338910 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757056 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2ccccc2Cl)c2ccccc12 InChI=1S/C24H19ClN6O/c1-32-21-14-27-24(29-23(21)28-17-10-12-26-13-11-17)22-18-7-3-5-9-20(18)31(30-22)15-16-6-2-4-8-19(16)25/h2-14H,15H2,1H3,(H,26,27,28,29) BYVNZVOOTRYALJ-UHFFFAOYSA-N 378917 2-[1-(2- chlorobenzyl)- 1H-indazol-3-yl]- 5-methoxy-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 2-10-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 6.70 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378917 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378917&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71553358 404338911 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757057 COc1cnc(nc1N(Cc1ccccc1Cl)c1ccncc1)-c1nn(Cc2ccccc2Cl)c2ccccc12 InChI=1S/C31H24Cl2N6O/c1-40-28-18-35-30(29-24-10-4-7-13-27(24)39(37-29)20-22-9-3-6-12-26(22)33)36-31(28)38(23-14-16-34-17-15-23)19-21-8-2-5-11-25(21)32/h2-18H,19-20H2,1H3 NVNBRIKKBSTAPK-UHFFFAOYSA-N 378918 N-(2- chlorobenzyl)-2- [1-(2- chlorobenzyl)- 1H-indazol-3-yl]- 5-methoxy-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 2-10-2 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 1200 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378918 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378918&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71553359 404338912 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757058 COC(=O)c1ccc(Cn2nc(-c3ncc(OC)c(Nc4ccncc4)n3)c3ccccc23)c(Cl)c1 InChI=1S/C26H21ClN6O3/c1-35-22-14-29-25(31-24(22)30-18-9-11-28-12-10-18)23-19-5-3-4-6-21(19)33(32-23)15-17-8-7-16(13-20(17)27)26(34)36-2/h3-14H,15H2,1-2H3,(H,28,29,30,31) YGEJZWNWYDVTHN-UHFFFAOYSA-N 378919 US10266548, Example 2-11-1::methyl 3-chloro- 4-({3-[5- methoxy-4- (pyridin-4- ylamino) pyrimidin- 2-yl]-1H-indazol- 1- yl}methyl) benzoate Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 7.10 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378919 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378919&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71553360 404338913 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757059 COC(=O)c1ccc(CN(c2ccncc2)c2nc(ncc2OC)-c2nn(Cc3ccc(cc3Cl)C(=O)OC)c3ccccc23)c(Cl)c1 InChI=1S/C35H28Cl2N6O5/c1-46-30-18-39-32(31-26-6-4-5-7-29(26)43(41-31)20-24-11-9-22(17-28(24)37)35(45)48-3)40-33(30)42(25-12-14-38-15-13-25)19-23-10-8-21(16-27(23)36)34(44)47-2/h4-18H,19-20H2,1-3H3 XJJVSJIISUBPJW-UHFFFAOYSA-N 378920 US10266548, Example 2-11-2::methyl 3-chloro- 4-{[(2-{1-[2- chloro-4- (methoxycar- bonyl)benzyl]- 1H-indazol-3-yl}- 5- methoxypyrimidin- 4-yl)(pyridin-4- yl)amino]methyl} benzoate Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 540 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378920 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378920&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71553448 404338914 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757060 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2c(F)cc(Br)cc2F)c2ccccc12 InChI=1S/C24H17BrF2N6O/c1-34-21-12-29-24(31-23(21)30-15-6-8-28-9-7-15)22-16-4-2-3-5-20(16)33(32-22)13-17-18(26)10-14(25)11-19(17)27/h2-12H,13H2,1H3,(H,28,29,30,31) MCMKRKYCVROEAI-UHFFFAOYSA-N 378921 2-[1-(4-bromo- 2,6- difluorobenzyl)- 1H-indazol-3-yl]- 5-methoxy-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 2-12-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 7.30 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378921 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378921&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71553449 404338915 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757061 COC1=C(N\C=C\C=N/C=C)NC(N=C1)c1nn(Cc2ccc(F)c(OC)c2Cl)c2ccccc12 InChI=1S/C25H24ClFN6O2/c1-4-28-12-7-13-29-24-20(34-2)14-30-25(31-24)22-17-8-5-6-9-19(17)33(32-22)15-16-10-11-18(27)23(35-3)21(16)26/h4-14,25,29,31H,1,15H2,2-3H3/b13-7+,28-12- WTGNOIWGZGCKIH-VTLKSVKASA-N 378922 2-[1-(2-chloro-4- fluoro-3- methoxybenzyl)- 1H-indazol-3-yl]- 5-methoxy-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 2-13-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 8.00 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378922 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378922&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 130417015 404338916 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757062 CCOc1ccc(Cn2nc(-c3ncc(OC)c(Nc4ccncc4)n3)c3ccccc23)c(F)c1F InChI=1S/C26H22F2N6O2/c1-3-36-20-9-8-16(22(27)23(20)28)15-34-19-7-5-4-6-18(19)24(33-34)26-30-14-21(35-2)25(32-26)31-17-10-12-29-13-11-17/h4-14H,3,15H2,1-2H3,(H,29,30,31,32) BXHVRUYHPOGGNE-UHFFFAOYSA-N 378923 2-[1-(4-ethoxy- 2,3- difluorobenzyl)- 1H-indazol-3-yl]- 5-methoxy-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 2-14-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 8.30 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378923 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378923&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71553451 404338917 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757063 CCOc1ccc(CN(c2ccncc2)c2nc(ncc2OC)-c2nn(Cc3ccc(OCC)c(F)c3F)c3ccccc23)c(F)c1F InChI=1S/C35H30F4N6O3/c1-4-47-26-12-10-21(29(36)31(26)38)19-44(23-14-16-40-17-15-23)35-28(46-3)18-41-34(42-35)33-24-8-6-7-9-25(24)45(43-33)20-22-11-13-27(48-5-2)32(39)30(22)37/h6-18H,4-5,19-20H2,1-3H3 OQNKVMHAJKFFFQ-UHFFFAOYSA-N 378924 N-(4-ethoxy-2,3- difluorobenzyl)- 2-[1-(4-ethoxy- 2,3- difluorobenzyl)- 1H-indazol-3-yl]- 5-methoxy-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 2-14-2 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 730 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378924 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378924&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71553452 404338918 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757064 CO\C=C(/Nc1ccncc1)\N=C(/N=C)c1nn(Cc2c(F)c(F)c(OCC(F)(F)F)c(F)c2F)c2ccccc12 InChI=1S/C26H19F7N6O2/c1-34-25(37-18(12-40-2)36-14-7-9-35-10-8-14)23-15-5-3-4-6-17(15)39(38-23)11-16-19(27)21(29)24(22(30)20(16)28)41-13-26(31,32)33/h3-10,12H,1,11,13H2,2H3,(H,35,36)/b18-12+,37-25- UHRCEMNAOZKSMM-MGKPIMCQSA-N 378925 5-methoxy-N- (pyridin-4-yl)-2- {1-[2,3,5,6- tetrafluoro-4- (2,2,2- trifluoroethoxy) benzyl]-1H- indazol-3- yl}pyrimidin-4- amine::US10266548, Example 2-15-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 38.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378925 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378925&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 130417017 404338919 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757065 COc1cnc(nc1N(Cc1c(F)c(F)c(OCC(F)(F)F)c(F)c1F)c1ccncc1)-c1nn(Cc2c(F)c(F)c(OCC(F)(F)F)c(F)c2F)c2ccccc12 InChI=1S/C35H20F14N6O3/c1-56-20-10-51-32(29-16-4-2-3-5-19(16)55(53-29)12-18-23(38)27(42)31(28(43)24(18)39)58-14-35(47,48)49)52-33(20)54(15-6-8-50-9-7-15)11-17-21(36)25(40)30(26(41)22(17)37)57-13-34(44,45)46/h2-10H,11-14H2,1H3 UIUCTJUDUDMFHT-UHFFFAOYSA-N 378926 5-methoxy-N- (pyridin-4-yl)-N- [2,3,5,6- tetrafluoro-4- (2,2,2- trifluoroethoxy) benzyl]-2-{1- [2,3,5,6- tetrafluoro-4- (2,2,2- trifluoroethoxy) benzyl]-1H- indazol-3- yl}pyrimidin-4- amine::US10266548, Example 2-15-2 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 3200 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378926 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378926&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71553531 404338920 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757066 COC(=O)c1ccc(Cl)c(Cn2nc(-c3ncc(OC)c(NC4=CCNC=C4)n3)c3ccccc23)c1Cl InChI=1S/C26H22Cl2N6O3/c1-36-21-13-30-25(32-24(21)31-15-9-11-29-12-10-15)23-16-5-3-4-6-20(16)34(33-23)14-18-19(27)8-7-17(22(18)28)26(35)37-2/h3-11,13,29H,12,14H2,1-2H3,(H,30,31,32) OKOUEQICNSVVKG-UHFFFAOYSA-N 378927 US10266548, Example 2-16-1::methyl 2,4- dichloro-3-({3-[5- methoxy-4- (pyridin-4- ylamino) pyrimidin- 2-yl]-1H-indazol- 1- yl}methyl) benzoate Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 8.40 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378927 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378927&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 130417018 404338921 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757067 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2c(F)cc(F)cc2F)c2ccccc12 InChI=1S/C24H17F3N6O/c1-34-21-12-29-24(31-23(21)30-15-6-8-28-9-7-15)22-16-4-2-3-5-20(16)33(32-22)13-17-18(26)10-14(25)11-19(17)27/h2-12H,13H2,1H3,(H,28,29,30,31) FEEVMVAILSFBJS-UHFFFAOYSA-N 378928 5-methoxy-N- (pyridin-4-yl)-2- [1-(2,4,6- trifluorobenzyl)- 1H-indazol-3- yl]pyrimidin-4- amine::US10266548, Example 2-17-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 8.80 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378928 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378928&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71553533 404338922 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757068 COc1cnc(nc1N(Cc1c(F)cc(F)cc1F)c1ccncc1)-c1nn(Cc2c(F)cc(F)cc2F)c2ccccc12 InChI=1S/C31H20F6N6O/c1-44-28-14-39-30(29-20-4-2-3-5-27(20)43(41-29)16-22-25(36)12-18(33)13-26(22)37)40-31(28)42(19-6-8-38-9-7-19)15-21-23(34)10-17(32)11-24(21)35/h2-14H,15-16H2,1H3 BYCLFTVBRYWWEN-UHFFFAOYSA-N 378929 5-methoxy-N- (pyridin-4-yl)-N- (2,4,6- trifluorobenzyl)- 2-[1-(2,4,6- trifluorobenzyl)- 1H-indazol-3- yl]pyrimidin-4- amine::US10266548, Example 2-17-2 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 890 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378929 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378929&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71553616 404338923 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757069 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2ccccc2F)c2ccccc12 InChI=1S/C24H19FN6O/c1-32-21-14-27-24(29-23(21)28-17-10-12-26-13-11-17)22-18-7-3-5-9-20(18)31(30-22)15-16-6-2-4-8-19(16)25/h2-14H,15H2,1H3,(H,26,27,28,29) WXZBIHKYDPLPOR-UHFFFAOYSA-N 378930 2-[1-(2- fluorobenzyl)- 1H-indazol-3-yl]- 5-methoxy-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 2-18-1::US10266548, Example 24-3 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 13.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378930 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378930&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71553617 404338924 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757070 COc1cnc(nc1NC1=CCNC=C1)-c1nn(Cc2ccc(Cl)cc2Cl)c2ccccc12 InChI=1S/C24H20Cl2N6O/c1-33-21-13-28-24(30-23(21)29-17-8-10-27-11-9-17)22-18-4-2-3-5-20(18)32(31-22)14-15-6-7-16(25)12-19(15)26/h2-10,12-13,27H,11,14H2,1H3,(H,28,29,30) XYKWGXQIXSYQRL-UHFFFAOYSA-N 378931 2-[1-(2,4- dichlorobenzyl)- 1H-indazol-3-yl]- 5-methoxy-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 2-19-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 10.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378931 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378931&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 130417016 404338925 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757071 COc1ccc(F)c(Cn2nc(-c3ncc(OC)c(Nc4ccncc4)n3)c3ccccc23)c1F InChI=1S/C25H20F2N6O2/c1-34-20-8-7-18(26)17(22(20)27)14-33-19-6-4-3-5-16(19)23(32-33)25-29-13-21(35-2)24(31-25)30-15-9-11-28-12-10-15/h3-13H,14H2,1-2H3,(H,28,29,30,31) DJDRRVBSAWOMEX-UHFFFAOYSA-N 378932 2-[1-(6-chloro-2- fluoro-3- methoxybenzyl)- 1H-indazol-3-yl]- 5-methoxy-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 2-2-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 2.60 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378932 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378932&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71554480 404338926 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757072 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2cccc(c2)-c2noc(C)n2)c2ccccc12 InChI=1S/C27H22N8O2/c1-17-30-25(34-37-17)19-7-5-6-18(14-19)16-35-22-9-4-3-8-21(22)24(33-35)27-29-15-23(36-2)26(32-27)31-20-10-12-28-13-11-20/h3-15H,16H2,1-2H3,(H,28,29,31,32) KUVPSLOVIRBFMV-UHFFFAOYSA-N 378933 5-methoxy-2- {1-[3-(5- methyl-1,2,4- oxadiazol-3- yl)benzyl]-1H- indazol-3-yl}- N-(pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 2-2-3 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 25.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378933 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378933&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71554482 404338927 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757073 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2ccc(I)cc2F)c2ccccc12 InChI=1S/C24H18FIN6O/c1-33-21-13-28-24(30-23(21)29-17-8-10-27-11-9-17)22-18-4-2-3-5-20(18)32(31-22)14-15-6-7-16(26)12-19(15)25/h2-13H,14H2,1H3,(H,27,28,29,30) SDDZMWQDRJTZHB-UHFFFAOYSA-N 378934 2-[1-(2-fluoro-4- iodobenzyl)-1H- indazol-3-yl]-5- methoxy-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 2-20-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 11.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378934 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378934&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71553620 404338928 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757074 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2ccccc2Br)c2ccccc12 InChI=1S/C24H19BrN6O/c1-32-21-14-27-24(29-23(21)28-17-10-12-26-13-11-17)22-18-7-3-5-9-20(18)31(30-22)15-16-6-2-4-8-19(16)25/h2-14H,15H2,1H3,(H,26,27,28,29) BIPJTLAJTZHRNK-UHFFFAOYSA-N 378935 2-[1-(2- bromobenzyl)- 1H-indazol-3-yl]- 5-methoxy-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 2-21-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 12.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378935 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378935&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71553697 404338929 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757075 COc1cnc(nc1N(Cc1ccccc1Br)c1ccncc1)-c1nn(Cc2ccccc2Br)c2ccccc12 InChI=1S/C31H24Br2N6O/c1-40-28-18-35-30(29-24-10-4-7-13-27(24)39(37-29)20-22-9-3-6-12-26(22)33)36-31(28)38(23-14-16-34-17-15-23)19-21-8-2-5-11-25(21)32/h2-18H,19-20H2,1H3 AEQLCZMJIFFRGD-UHFFFAOYSA-N 378936 N-(2- bromobenzyl)-2- [1-(2- bromobenzyl)- 1H-indazol-3-yl]- 5-methoxy-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 2-21-2 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 20000 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378936 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378936&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71553698 404338930 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757076 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2ccc(CC(O)=O)cc2F)c2ccccc12 InChI=1S/C26H21FN6O3/c1-36-22-14-29-26(31-25(22)30-18-8-10-28-11-9-18)24-19-4-2-3-5-21(19)33(32-24)15-17-7-6-16(12-20(17)27)13-23(34)35/h2-12,14H,13,15H2,1H3,(H,34,35)(H,28,29,30,31) QNBXYFOYPKQGDK-UHFFFAOYSA-N 378937 US10266548, Example 2-22-1::[3-fluoro-4-({3- [5-methoxy-4- (pyridin-4- ylamino) pyrimidin- 2-yl]-1H-indazol- 1- yl}methyl)phenyl] acetic acid Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 3200 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378937 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378937&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71553619 404338931 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757077 COc1ccc(Cn2nc(-c3ncc(OC)c(Nc4ccncc4)n3)c3ccccc23)cc1 InChI=1S/C25H22N6O2/c1-32-19-9-7-17(8-10-19)16-31-21-6-4-3-5-20(21)23(30-31)25-27-15-22(33-2)24(29-25)28-18-11-13-26-14-12-18/h3-15H,16H2,1-2H3,(H,26,27,28,29) JFFWKJXVVIVTKT-UHFFFAOYSA-N 378938 5-methoxy-2-[1- (4- methoxybenzyl)- 1H-indazol-3-yl]- N-(pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 2-23-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 13.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378938 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378938&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 86732417 404338932 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757078 COc1cnc(nc1)-c1nn(Cc2c(F)c(F)c(OC)c(F)c2F)c2ccccc12 InChI=1S/C20H14F4N4O2/c1-29-10-7-25-20(26-8-10)18-11-5-3-4-6-13(11)28(27-18)9-12-14(21)16(23)19(30-2)17(24)15(12)22/h3-8H,9H2,1-2H3 LLDWLPHGPXDYDO-UHFFFAOYSA-N 378939 5-methoxy-N- (pyridin-4-yl)-2- [1-(2,3,5,6- tetrafluoro-4- methoxybenzyl)- 1H-indazol-3- yl]pyrimidin-4- amine::US10266548, Example 2-24-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 14.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378939 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378939&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 130417027 404338933 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757079 CCCc1ccc(Cn2nc(-c3ncc(OC)c(Nc4ccncc4)n3)c3ccccc23)cc1 InChI=1S/C27H26N6O/c1-3-6-19-9-11-20(12-10-19)18-33-23-8-5-4-7-22(23)25(32-33)27-29-17-24(34-2)26(31-27)30-21-13-15-28-16-14-21/h4-5,7-17H,3,6,18H2,1-2H3,(H,28,29,30,31) LZYSCUWOEJDACW-UHFFFAOYSA-N 378940 5-methoxy-2-[1- (4-propylbenzyl)- 1H-indazol-3-yl]- N-(pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 2-25-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 15.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378940 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378940&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71553700 404338934 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757080 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2c(Cl)cc(OC(F)(F)F)cc2Cl)c2ccccc12 InChI=1S/C25H17Cl2F3N6O2/c1-37-21-12-32-24(34-23(21)33-14-6-8-31-9-7-14)22-16-4-2-3-5-20(16)36(35-22)13-17-18(26)10-15(11-19(17)27)38-25(28,29)30/h2-12H,13H2,1H3,(H,31,32,33,34) ZTLBYWPUJKXMJM-UHFFFAOYSA-N 378941 2-{1-[2,6- dichloro-4- (trifluoromethoxy) benzyl]-1H- indazol-3-yl}-5- methoxy-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 2-26-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 16.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378941 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378941&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71553701 404338935 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757081 COc1cnc(nc1N(Cc1c(Cl)cc(OC(F)(F)F)cc1Cl)\C=C\C=N/C=C)-c1nn(Cc2c(Cl)cc(OC(F)(F)F)cc2Cl)c2ccccc12 InChI=1S/C33H22Cl4F6N6O3/c1-3-44-9-6-10-48(16-21-23(34)11-18(12-24(21)35)51-32(38,39)40)31-28(50-2)15-45-30(46-31)29-20-7-4-5-8-27(20)49(47-29)17-22-25(36)13-19(14-26(22)37)52-33(41,42)43/h3-15H,1,16-17H2,2H3/b10-6+,44-9- QJWHVUMCUMYMCX-KEVPOYGISA-N 378942 N-[2,6-dichloro- 4- (trifluoromethoxy) benzyl]-2-{1- [2,6-dichloro-4- (trifluoromethoxy) benzyl]-1H- indazol-3-yl}-5- methoxy-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 2-26-2 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 840 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378942 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378942&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 130417029 404338936 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757082 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2ccc3CCC(=O)Nc3c2)c2ccccc12 InChI=1S/C27H23N7O2/c1-36-23-15-29-27(32-26(23)30-19-10-12-28-13-11-19)25-20-4-2-3-5-22(20)34(33-25)16-17-6-7-18-8-9-24(35)31-21(18)14-17/h2-7,10-15H,8-9,16H2,1H3,(H,31,35)(H,28,29,30,32) VRLKNPZBSCXHMW-UHFFFAOYSA-N 378943 7-({3-[5- methoxy-4- (pyridin-4- ylamino) pyrimidin- 2-yl]-1H-indazol- 1-yl}methyl)-3,4- dihydroquinolin- 2(1H)-one::US10266548, Example 2-27-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 20.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378943 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378943&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71553784 404338937 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757083 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2ccc(I)cc2Cl)c2ccccc12 InChI=1S/C24H18ClIN6O/c1-33-21-13-28-24(30-23(21)29-17-8-10-27-11-9-17)22-18-4-2-3-5-20(18)32(31-22)14-15-6-7-16(26)12-19(15)25/h2-13H,14H2,1H3,(H,27,28,29,30) VBJOZAJERNYGPU-UHFFFAOYSA-N 378944 2-[1-(2-chloro-4- iodobenzyl)-1H- indazol-3-yl]-5- methoxy-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 2-28-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 22.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378944 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378944&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71553785 404338938 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757084 COc1cc(Cn2nc(-c3ncc(OC)c(NC4=CCNC=C4)n3)c3ccccc23)cc(OC)c1 InChI=1S/C26H26N6O3/c1-33-19-12-17(13-20(14-19)34-2)16-32-22-7-5-4-6-21(22)24(31-32)26-28-15-23(35-3)25(30-26)29-18-8-10-27-11-9-18/h4-10,12-15,27H,11,16H2,1-3H3,(H,28,29,30) WDMGRNRCPJWLIW-UHFFFAOYSA-N 378945 2-[1-(3,5- dimethoxybenzyl)- 1H-indazol- 3-yl]-5-methoxy- N-(pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 2-29-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 23.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378945 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378945&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 130417021 404338939 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757085 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2cc(C)c(C)cc2Cl)c2ccccc12 InChI=1S/C26H23ClN6O/c1-16-12-18(21(27)13-17(16)2)15-33-22-7-5-4-6-20(22)24(32-33)26-29-14-23(34-3)25(31-26)30-19-8-10-28-11-9-19/h4-14H,15H2,1-3H3,(H,28,29,30,31) YAAVWYIZLHIKKG-UHFFFAOYSA-N 378946 2-[1-(2-chloro- 4,5- dimethylbenzyl)- 1H-indazol-3-yl]- 5-methoxy-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 2-3-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 4.40 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378946 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378946&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71554401 404338940 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757086 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2ccc(cc2)S(F)(F)(F)(F)F)c2ccccc12 InChI=1S/C24H19F5N6OS/c1-36-21-14-31-24(33-23(21)32-17-10-12-30-13-11-17)22-19-4-2-3-5-20(19)35(34-22)15-16-6-8-18(9-7-16)37(25,26,27,28)29/h2-14H,15H2,1H3,(H,30,31,32,33) CBESQGHDYHKHKR-UHFFFAOYSA-N 378947 5-methoxy-2- {1-[4- (pentafluoro- lambda6- sulfanyl) benzyl]- 1H-indazol-3- yl}-N-(pyridin- 4-yl)pyrimidin- 4-amine::US10266548, Example 2-3-3 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 360 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378947 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378947&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89495345 404338941 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757087 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2c(Cl)cccc2C(F)(F)F)c2ccccc12 InChI=1S/C25H18ClF3N6O/c1-36-21-13-31-24(33-23(21)32-15-9-11-30-12-10-15)22-16-5-2-3-8-20(16)35(34-22)14-17-18(25(27,28)29)6-4-7-19(17)26/h2-13H,14H2,1H3,(H,30,31,32,33) LQEJANIPIWOBGL-UHFFFAOYSA-N 378948 2-{1-[2-chloro-6- (trifluoromethyl) benzyl]-1H- indazol-3-yl}-5- methoxy-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 2-30-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 23.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378948 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378948&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71553787 404338942 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757088 CO\C=C(/Nc1ccncc1)\N=C(/N=C)c1nn(Cc2cc(F)ccc2Cl)c2ccccc12 InChI=1S/C24H20ClFN6O/c1-27-24(30-22(15-33-2)29-18-9-11-28-12-10-18)23-19-5-3-4-6-21(19)32(31-23)14-16-13-17(26)7-8-20(16)25/h3-13,15H,1,14H2,2H3,(H,28,29)/b22-15+,30-24- NUBNJKZWZJRKGX-KSDBWNJBSA-N 378949 2-[1-(2-chloro-5- fluorobenzyl)- 1H-indazol-3-yl]- 5-methoxy-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 2-31-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 28.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378949 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378949&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 130417022 404338943 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757089 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2ccc3c(C)cc(=O)oc3c2)c2ccccc12 InChI=1S/C28H22N6O3/c1-17-13-25(35)37-23-14-18(7-8-20(17)23)16-34-22-6-4-3-5-21(22)26(33-34)28-30-15-24(36-2)27(32-28)31-19-9-11-29-12-10-19/h3-15H,16H2,1-2H3,(H,29,30,31,32) JZYKJOOTBJULAY-UHFFFAOYSA-N 378950 7-({3-[5- methoxy-4- (pyridin-4- ylamino) pyrimidin- 2-yl]-1H-indazol- 1-yl}methyl)-4- methyl-2H- chromen-2-one::US10266548, Example 2-32-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 29.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378950 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378950&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71553874 404338944 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757090 COC1=C(N\C=C\C=N/C=C)NC(N=C1)c1nn(Cc2ccc(cc2F)C#N)c2ccccc12 InChI=1S/C25H22FN7O/c1-3-28-11-6-12-29-24-22(34-2)15-30-25(31-24)23-19-7-4-5-8-21(19)33(32-23)16-18-10-9-17(14-27)13-20(18)26/h3-13,15,25,29,31H,1,16H2,2H3/b12-6+,28-11- LSSGLUZKLOFYAL-MNYSSWDUSA-N 378951 3-fluoro-4-({3-[5- methoxy-4- (pyridin-4- ylamino) pyrimidin- 2-yl]-1H-indazol- 1- yl}methyl) benzonitrile::US10266548, Example 2-33-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 38.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378951 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378951&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 130417019 404338945 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757091 COc1cnc(nc1N(Cc1ccc(cc1F)C#N)c1ccncc1)-c1nn(Cc2ccc(cc2F)C#N)c2ccccc12 InChI=1S/C33H22F2N8O/c1-44-30-18-39-32(31-26-4-2-3-5-29(26)43(41-31)20-24-9-7-22(17-37)15-28(24)35)40-33(30)42(25-10-12-38-13-11-25)19-23-8-6-21(16-36)14-27(23)34/h2-15,18H,19-20H2,1H3 PPRMWWWVPIPBPP-UHFFFAOYSA-N 378952 4-{[{2-[1-(4- cyano-2- fluorobenzyl)- 1H-indazol-3-yl]- 5- methoxypyrimidin- 4-yl}(pyridin- 4- yl)amino]methyl}- 3- fluorobenzo- nitrile::US10266548, Example 2-33-2 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 1100 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378952 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378952&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71553875 404338946 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757092 COc1cnc(nc1NC1=CCNC=C1)-c1nn(Cc2c(Cl)ccc(c2Cl)C(F)(F)F)c2ccccc12 InChI=1S/C25H19Cl2F3N6O/c1-37-20-12-32-24(34-23(20)33-14-8-10-31-11-9-14)22-15-4-2-3-5-19(15)36(35-22)13-16-18(26)7-6-17(21(16)27)25(28,29)30/h2-10,12,31H,11,13H2,1H3,(H,32,33,34) MLSQBNAEAJLLEA-UHFFFAOYSA-N 378953 2-{1-(2,6- dichloro-3- (trifluoromethyl) benzyl]-1H- indazol-3-yl}-5- methoxy-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 2-34-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 38.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378953 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378953&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 130417028 404338947 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757093 CCOC(=O)Cc1cccc(Cn2nc(-c3ncc(OC)c(NC4=CCNC=C4)n3)c3ccccc23)c1 InChI=1S/C28H28N6O3/c1-3-37-25(35)16-19-7-6-8-20(15-19)18-34-23-10-5-4-9-22(23)26(33-34)28-30-17-24(36-2)27(32-28)31-21-11-13-29-14-12-21/h4-13,15,17,29H,3,14,16,18H2,1-2H3,(H,30,31,32) UDBVYDQYEQZXSU-UHFFFAOYSA-N 378954 US10266548, Example 2-35-1::ethyl [3-({3-[5- methoxy-4- (pyridin-4- ylamino) pyrimidin- 2-yl]-1H-indazol- 1- yl}methyl)phenyl] acetate Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 52.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378954 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378954&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 130417020 404338948 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757094 COc1cnc(nc1NC1=CCNC=C1)-c1nn(Cc2ccc(F)cc2)c2ccccc12 InChI=1S/C24H21FN6O/c1-32-21-14-27-24(29-23(21)28-18-10-12-26-13-11-18)22-19-4-2-3-5-20(19)31(30-22)15-16-6-8-17(25)9-7-16/h2-12,14,26H,13,15H2,1H3,(H,27,28,29) RBRILCSPHAGSIW-UHFFFAOYSA-N 378955 2-[1-(4- fluorobenzyl)- 1H-indazol-3-yl]- 5-methoxy-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 2-36-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 58.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378955 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378955&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 130417026 404338949 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757095 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2ccc(cc2)S(=O)(=O)NC2CC2)c2ccccc12 InChI=1S/C27H25N7O3S/c1-37-24-16-29-27(31-26(24)30-19-12-14-28-15-13-19)25-22-4-2-3-5-23(22)34(32-25)17-18-6-10-21(11-7-18)38(35,36)33-20-8-9-20/h2-7,10-16,20,33H,8-9,17H2,1H3,(H,28,29,30,31) ILZCMUJGNSICCW-UHFFFAOYSA-N 378956 N-cyclopropyl-4- ({3-[5-methoxy- 4-(pyridin-4- ylamino) pyrimidin- 2-yl]-1H-indazol- 1- yl}methyl)ben- zenesulfonamide::US10266548, Example 2-37-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 71.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378956 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378956&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71553964 404338950 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757096 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2ccc3CC(=O)Oc3c2)c2ccccc12 InChI=1S/C26H20N6O3/c1-34-22-14-28-26(30-25(22)29-18-8-10-27-11-9-18)24-19-4-2-3-5-20(19)32(31-24)15-16-6-7-17-13-23(33)35-21(17)12-16/h2-12,14H,13,15H2,1H3,(H,27,28,29,30) GGKSQPCLIYZTKR-UHFFFAOYSA-N 378957 6-({3-[5- methoxy-4- (pyridin-4- ylamino) pyrimidin- 2-yl]-1H-indazol- 1-yl}methyl)-1- benzofuran- 2(3H)-one::US10266548, Example 2-38-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 76.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378957 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378957&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71553965 404338951 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757097 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2c(F)cc(OC(F)F)cc2F)c2ccccc12 InChI=1S/C25H18F4N6O2/c1-36-21-12-31-24(33-23(21)32-14-6-8-30-9-7-14)22-16-4-2-3-5-20(16)35(34-22)13-17-18(26)10-15(11-19(17)27)37-25(28)29/h2-12,25H,13H2,1H3,(H,30,31,32,33) HMYZSKXZCBAPOP-UHFFFAOYSA-N 378958 2-{1-[4- (difluoro- methoxy)-2,6- difluorobenzyl]- 1H-indazol-3-yl}- 5-methoxy-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 2-39-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 5.60 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378958 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378958&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71553966 404338952 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757098 COc1cnc(nc1N(Cc1c(F)cc(OC(F)F)cc1F)c1ccncc1)-c1nn(Cc2c(F)cc(OC(F)F)cc2F)c2ccccc12 InChI=1S/C33H22F8N6O3/c1-48-28-14-43-30(29-20-4-2-3-5-27(20)47(45-29)16-22-25(36)12-19(13-26(22)37)50-33(40)41)44-31(28)46(17-6-8-42-9-7-17)15-21-23(34)10-18(11-24(21)35)49-32(38)39/h2-14,32-33H,15-16H2,1H3 DEMBFHYJSGAJDL-UHFFFAOYSA-N 378959 N-[4- (difluoromethoxy)- 2,6- difluorobenzyl]- 2-{1-[4- (difluoromethoxy)- 2,6- difluorobenzyl]- 1H-indazol-3-yl}- 5-methoxy-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 2-39-2 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 6900 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378959 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378959&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71554141 404338953 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757099 COc1ccc(F)c(CN(\N=C\c2ncc(OC)c(Nc3ccncc3)n2)c2ccccc2)c1F InChI=1S/C25H22F2N6O2/c1-34-21-9-8-20(26)19(24(21)27)16-33(18-6-4-3-5-7-18)30-15-23-29-14-22(35-2)25(32-23)31-17-10-12-28-13-11-17/h3-15H,16H2,1-2H3,(H,28,29,31,32)/b30-15+ XCZLFLKRAMORNY-FJEPWZHXSA-N 378960 2-[1-(2,6- difluoro-3- methoxybenzyl)- 1H-indazol-3-yl]- 5-methoxy-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 2-4-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 4.50 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378960 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378960&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 130417012 404338954 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757100 COc1ccc(F)c(CN(c2ccncc2)c2nc(ncc2OC)-c2nn(Cc3c(F)ccc(OC)c3F)c3ccccc23)c1F InChI=1S/C33H26F4N6O3/c1-44-26-10-8-23(34)21(29(26)36)17-42(19-12-14-38-15-13-19)33-28(46-3)16-39-32(40-33)31-20-6-4-5-7-25(20)43(41-31)18-22-24(35)9-11-27(45-2)30(22)37/h4-16H,17-18H2,1-3H3 YREZZCPGACJNTA-UHFFFAOYSA-N 378961 N-(2,6-difluoro- 3- methoxybenzyl)- 2-[1-(2,6- difluoro-3- methoxybenzyl)- 1H-indazol-3-yl]- 5-methoxy-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 2-4-2 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 3500 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378961 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378961&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71554483 404338955 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757101 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2cc3OCOc3cc2Br)c2ccccc12 InChI=1S/C25H19BrN6O3/c1-33-22-12-28-25(30-24(22)29-16-6-8-27-9-7-16)23-17-4-2-3-5-19(17)32(31-23)13-15-10-20-21(11-18(15)26)35-14-34-20/h2-12H,13-14H2,1H3,(H,27,28,29,30) MIMPQPQAUQUSBY-UHFFFAOYSA-N 378962 2-{1-[(6- bromo-1,3- benzodioxol- 5-yl)methyl]- 1H-indazol-3- yl}-5-methoxy- N-(pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 2-4-3 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 14.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378962 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378962&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71554481 404338956 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757102 COc1cnc(\C=N\N(Cc2ccc(cc2Cl)C(=O)OC(C)(C)C)c2ccccc2)nc1Nc1ccncc1 InChI=1S/C29H29ClN6O3/c1-29(2,3)39-28(37)20-10-11-21(24(30)16-20)19-36(23-8-6-5-7-9-23)33-18-26-32-17-25(38-4)27(35-26)34-22-12-14-31-15-13-22/h5-18H,19H2,1-4H3,(H,31,32,34,35)/b33-18+ PBCHOFZHOVLRLQ-DPNNOFEESA-N 378963 US10266548, Example 2-40-1::tert-butyl 3- chloro-4-({3-[5- methoxy-4- (pyridin-4- ylamino) pyrimidin- 2-yl]-1H-indazol- 1- yl}methyl) benzoate Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 120 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378963 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378963&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 130417023 404338957 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757103 CCOC(=O)C(C)(C)c1cccc(Cn2nc(-c3ncc(OC)c(Nc4ccncc4)n3)c3ccccc23)c1 InChI=1S/C30H30N6O3/c1-5-39-29(37)30(2,3)21-10-8-9-20(17-21)19-36-24-12-7-6-11-23(24)26(35-36)28-32-18-25(38-4)27(34-28)33-22-13-15-31-16-14-22/h6-18H,5,19H2,1-4H3,(H,31,32,33,34) MLZMPTQKYGVXMT-UHFFFAOYSA-N 378964 US10266548, Example 2-41-1::ethyl 2-[3-({3-[5- methoxy-4- (pyridin-4- ylamino) pyrimidin- 2-yl]-1H-indazol- 1- yl}methyl)phenyl]- 2- methylpropanoate Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 150 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378964 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378964&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71554053 404338958 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757104 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2ccc(cc2)C#N)c2ccccc12 InChI=1S/C25H19N7O/c1-33-22-15-28-25(30-24(22)29-19-10-12-27-13-11-19)23-20-4-2-3-5-21(20)32(31-23)16-18-8-6-17(14-26)7-9-18/h2-13,15H,16H2,1H3,(H,27,28,29,30) REOVTPBXAGSDJT-UHFFFAOYSA-N 378965 4-({3-[5- methoxy-4- (pyridin-4- ylamino) pyrimidin- 2-yl]-1H-indazol- 1- yl}methyl)benzo- nitrile::US10266548, Example 2-42-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 190 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378965 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378965&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71554057 404338959 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757105 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2ccc(cc2)S(=O)(=O)N2CCOCC2)c2ccccc12 InChI=1S/C28H27N7O4S/c1-38-25-18-30-28(32-27(25)31-21-10-12-29-13-11-21)26-23-4-2-3-5-24(23)35(33-26)19-20-6-8-22(9-7-20)40(36,37)34-14-16-39-17-15-34/h2-13,18H,14-17,19H2,1H3,(H,29,30,31,32) PPHYUGSCBMJXTB-UHFFFAOYSA-N 378966 5-methoxy-2-{1- [4-(morpholin-4- ylsulfonyl)benzyl]- 1H-indazol-3- yl}-N-(pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 2-43-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 1200 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378966 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378966&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71554056 404338960 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757106 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2c(Cl)ccc(c2Cl)[N+]([O-])=O)c2ccccc12 InChI=1S/C24H17Cl2N7O3/c1-36-20-12-28-24(30-23(20)29-14-8-10-27-11-9-14)22-15-4-2-3-5-18(15)32(31-22)13-16-17(25)6-7-19(21(16)26)33(34)35/h2-12H,13H2,1H3,(H,27,28,29,30) LWJLBEUOLBKZGI-UHFFFAOYSA-N 378967 2-[1-(2,6- dichloro-3- nitrobenzyl)-1H- indazol-3-yl]-5- methoxy-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 2-44-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 41.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378967 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378967&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71554055 404338961 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757107 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2cccc(c2)C#N)c2ccccc12 InChI=1S/C25H19N7O/c1-33-22-15-28-25(30-24(22)29-19-9-11-27-12-10-19)23-20-7-2-3-8-21(20)32(31-23)16-18-6-4-5-17(13-18)14-26/h2-13,15H,16H2,1H3,(H,27,28,29,30) LURTUFLEIMXDRF-UHFFFAOYSA-N 378968 3-({3-[5- methoxy-4- (pyridin-4- ylamino) pyrimidin- 2-yl]-1H-indazol- 1- yl}methyl)benzo- nitrile::US10266548, Example 2-45-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 110 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378968 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378968&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71554054 404338962 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757108 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2c(F)cc(cc2F)C#N)c2ccccc12 InChI=1S/C25H17F2N7O/c1-35-22-13-30-25(32-24(22)31-16-6-8-29-9-7-16)23-17-4-2-3-5-21(17)34(33-23)14-18-19(26)10-15(12-28)11-20(18)27/h2-11,13H,14H2,1H3,(H,29,30,31,32) USXDRGYQHRQCBD-UHFFFAOYSA-N 378969 3,5-difluoro-4- ({3-[5-methoxy- 4-(pyridin-4- ylamino) pyrimidin- 2-yl]-1H-indazol- 1- yl}methyl)benzo- nitrile::US10266548, Example 2-46-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 16.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378969 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378969&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71554143 404338963 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757109 COc1cc(ccc1Cn1nc(-c2ncc(OC)c(Nc3ccncc3)n2)c2ccccc12)C(F)(F)F InChI=1S/C26H21F3N6O2/c1-36-21-13-17(26(27,28)29)8-7-16(21)15-35-20-6-4-3-5-19(20)23(34-35)25-31-14-22(37-2)24(33-25)32-18-9-11-30-12-10-18/h3-14H,15H2,1-2H3,(H,30,31,32,33) XGWTXOKPUWZDTO-UHFFFAOYSA-N 378970 5-methoxy-2-{1- [2-methoxy-4- (trifluoromethyl) benzyl]-1H- indazol-3-yl}-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 2-47-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 2400 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378970 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378970&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71554144 404338964 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757110 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2c(F)ccc(C)c2F)c2ccccc12 InChI=1S/C25H20F2N6O/c1-15-7-8-19(26)18(22(15)27)14-33-20-6-4-3-5-17(20)23(32-33)25-29-13-21(34-2)24(31-25)30-16-9-11-28-12-10-16/h3-13H,14H2,1-2H3,(H,28,29,30,31) HHOIUTMRYSJRCS-UHFFFAOYSA-N 378971 2-[1-(2,6- difluoro-3- methylbenzyl)- 1H-indazol-3-yl]- 5-methoxy-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 2-48-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 5.50 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378971 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378971&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71554145 404338965 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757111 COc1cccc(F)c1Cn1nc(-c2ncc(OC)c(Nc3ccncc3)n2)c2ccccc12 InChI=1S/C25H21FN6O2/c1-33-21-9-5-7-19(26)18(21)15-32-20-8-4-3-6-17(20)23(31-32)25-28-14-22(34-2)24(30-25)29-16-10-12-27-13-11-16/h3-14H,15H2,1-2H3,(H,27,28,29,30) DYAUAEMOQPKVDY-UHFFFAOYSA-N 378972 2-[1-(2-fluoro-6- methoxybenzyl)- 1H-indazol-3-yl]- 5-methoxy-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 2-49-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 1500 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378972 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378972&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71554228 404338966 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757112 CCOc1cc(F)c(Cn2nc(\C(N=C)=N\C(\Nc3ccncc3)=C\OC)c3ccccc23)c(F)c1 InChI=1S/C26H24F2N6O2/c1-4-36-18-13-21(27)20(22(28)14-18)15-34-23-8-6-5-7-19(23)25(33-34)26(29-2)32-24(16-35-3)31-17-9-11-30-12-10-17/h5-14,16H,2,4,15H2,1,3H3,(H,30,31)/b24-16+,32-26- KYVXAFASERGLBU-HFXRPDNNSA-N 378973 2-[1-(4-ethoxy- 2,6- difluorobenzyl)- 1H-indazol-3-yl]- 5-methoxy-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 2-5-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 4.60 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378973 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378973&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 130417013 404338967 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757113 CCOc1cc(F)c(CN(c2ccncc2)c2nc(ncc2OC)-c2nn(Cc3c(F)cc(OCC)cc3F)c3ccccc23)c(F)c1 InChI=1S/C35H30F4N6O3/c1-4-47-22-14-27(36)25(28(37)15-22)19-44(21-10-12-40-13-11-21)35-32(46-3)18-41-34(42-35)33-24-8-6-7-9-31(24)45(43-33)20-26-29(38)16-23(48-5-2)17-30(26)39/h6-18H,4-5,19-20H2,1-3H3 BJXOAPZSVVFJAQ-UHFFFAOYSA-N 378974 N-(4-ethoxy-2,6- difluorobenzyl)- 2-[1-(4-ethoxy- 2,6- difluorobenzyl)- 1H-indazol-3-yl]- 5-methoxy-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 2-5-2 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 9300 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378974 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378974&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71554484 404338968 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757114 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2ccccc2C#N)c2ccccc12 InChI=1S/C25H19N7O/c1-33-22-15-28-25(30-24(22)29-19-10-12-27-13-11-19)23-20-8-4-5-9-21(20)32(31-23)16-18-7-3-2-6-17(18)14-26/h2-13,15H,16H2,1H3,(H,27,28,29,30) LZNPFFXXYJZPEP-UHFFFAOYSA-N 378975 2-({3-[5- methoxy-4- (pyridin-4- ylamino) pyrimidin- 2-yl]-1H- indazol-1- yl}methyl) benzonitrile::US10266548, Example 2-5-3 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 21.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378975 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378975&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71554574 404338969 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757115 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2c(F)cc(cc2F)C(N)=O)c2ccccc12 InChI=1S/C25H19F2N7O2/c1-36-21-12-30-25(32-24(21)31-15-6-8-29-9-7-15)22-16-4-2-3-5-20(16)34(33-22)13-17-18(26)10-14(23(28)35)11-19(17)27/h2-12H,13H2,1H3,(H2,28,35)(H,29,30,31,32) OWTLXYWOTZZJSY-UHFFFAOYSA-N 378976 3,5-difluoro-4- ({3-[5-methoxy- 4-(pyridin-4- ylamino) pyrimidin- 2-yl]-1H-indazol- 1- yl}methyl) benzamide::US10266548, Example 2-50-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 11.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378976 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378976&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89495340 404338970 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757116 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2c(F)cc(OCCOC(C)=O)cc2F)c2ccccc12 InChI=1S/C28H24F2N6O4/c1-17(37)39-11-12-40-19-13-22(29)21(23(30)14-19)16-36-24-6-4-3-5-20(24)26(35-36)28-32-15-25(38-2)27(34-28)33-18-7-9-31-10-8-18/h3-10,13-15H,11-12,16H2,1-2H3,(H,31,32,33,34) PKQXMLOMAAADMQ-UHFFFAOYSA-N 378977 2-[3,5-difluoro-4- ({3-[5-methoxy- 4-(pyridin-4- ylamino) pyrimidin- 2-yl]-1H-indazol- 1- yl}methyl) phenoxy]ethyl acetate::US10266548, Example 2-51-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 10.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378977 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378977&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71554227 404338971 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757117 CCCOc1cc(F)c(Cn2nc(-c3ncc(OC)c(Nc4ccncc4)n3)c3ccccc23)c(F)c1 InChI=1S/C27H24F2N6O2/c1-3-12-37-18-13-21(28)20(22(29)14-18)16-35-23-7-5-4-6-19(23)25(34-35)27-31-15-24(36-2)26(33-27)32-17-8-10-30-11-9-17/h4-11,13-15H,3,12,16H2,1-2H3,(H,30,31,32,33) VRNKGIVQYZXMBF-UHFFFAOYSA-N 378978 2-[1-(2,6- difluoro-4- propoxybenzyl)- 1H-indazol-3-yl]- 5-methoxy-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 2-52-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 11.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378978 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378978&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89488608 404338972 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757118 CCOc1cc(F)c(Cn2nc(-c3ncc(OC)c(Nc4ccncc4)n3)c3ccccc23)c(OC)c1 InChI=1S/C27H25FN6O3/c1-4-37-18-13-21(28)20(23(14-18)35-2)16-34-22-8-6-5-7-19(22)25(33-34)27-30-15-24(36-3)26(32-27)31-17-9-11-29-12-10-17/h5-15H,4,16H2,1-3H3,(H,29,30,31,32) CDGZIQAELDKJRK-UHFFFAOYSA-N 378979 2-[1-(4-ethoxy- 2-fluoro-6- methoxybenzyl)- 1H-indazol- 3-yl]-5- methoxy-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 2-53-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 83.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378979 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378979&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71554229 404338973 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757119 COc1ccc(Cn2nc(-c3ncc(OC)c(Nc4ccncc4)n3)c3ccccc23)c(Cl)c1 InChI=1S/C25H21ClN6O2/c1-33-18-8-7-16(20(26)13-18)15-32-21-6-4-3-5-19(21)23(31-32)25-28-14-22(34-2)24(30-25)29-17-9-11-27-12-10-17/h3-14H,15H2,1-2H3,(H,27,28,29,30) NCIJLAVGESFEEC-UHFFFAOYSA-N 378980 2-[1-(2-chloro-4- methoxybenzyl)- 1H-indazol-3-yl]- 5-methoxy-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 2-6-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 4.70 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378980 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378980&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71554575 404338974 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757120 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2cccc3OCCCOc23)c2ccccc12 InChI=1S/C27H24N6O3/c1-34-23-16-29-27(31-26(23)30-19-10-12-28-13-11-19)24-20-7-2-3-8-21(20)33(32-24)17-18-6-4-9-22-25(18)36-15-5-14-35-22/h2-4,6-13,16H,5,14-15,17H2,1H3,(H,28,29,30,31) XBCQTAOUEKDBPS-UHFFFAOYSA-N 378981 2-[1-(3,4- dihydro-2H- 1,5-benzo- dioxepin-6- ylmethyl)-1H- indazol-3-yl]- 5-methoxy-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 2-6-3 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 59.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378981 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378981&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71554576 404338975 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757121 COc1cnc(nc1)-c1nn(Cc2c(F)cccc2F)c2ccccc12 InChI=1S/C19H14F2N4O/c1-26-12-9-22-19(23-10-12)18-13-5-2-3-8-17(13)25(24-18)11-14-15(20)6-4-7-16(14)21/h2-10H,11H2,1H3 GNMMJDOBXQBBEV-UHFFFAOYSA-N 378982 2-[1-(2,6- difluorobenzyl)- 1H-indazol-3-yl]- 5-methoxy-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 2-7-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 4.80 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378982 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378982&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 130417014 404338976 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757122 COc1cnc(nc1N(Cc1c(F)cccc1F)c1ccncc1)-c1nn(Cc2c(F)cccc2F)c2ccccc12 InChI=1S/C31H22F4N6O/c1-42-28-16-37-30(29-20-6-2-3-11-27(20)41(39-29)18-22-25(34)9-5-10-26(22)35)38-31(28)40(19-12-14-36-15-13-19)17-21-23(32)7-4-8-24(21)33/h2-16H,17-18H2,1H3 ZMDGNRHPSATBAF-UHFFFAOYSA-N 378983 N-(2,6- difluorobenzyl)- 2-[1-(2,6- difluorobenzyl)- 1H-indazol-3-yl]- 5-methoxy-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 2-7-2 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 210 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378983 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378983&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71553264 404338977 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757123 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2cccc(SC(F)(F)F)c2)c2ccccc12 InChI=1S/C25H19F3N6OS/c1-35-21-14-30-24(32-23(21)31-17-9-11-29-12-10-17)22-19-7-2-3-8-20(19)34(33-22)15-16-5-4-6-18(13-16)36-25(26,27)28/h2-14H,15H2,1H3,(H,29,30,31,32) BNDITAOVKWZYRH-UHFFFAOYSA-N 378984 5-methoxy-N- (pyridin-4-yl)- 2-(1-{3- [(trifluoromethyl) sulfanyl] benzyl}-1H- indazol-3- yl)pyrimidin-4- amine::US10266548, Example 2-7-3 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 430 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378984 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378984&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71553261 404338978 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757124 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2ccc(C)c(F)c2F)c2ccccc12 InChI=1S/C25H20F2N6O/c1-15-7-8-16(22(27)21(15)26)14-33-19-6-4-3-5-18(19)23(32-33)25-29-13-20(34-2)24(31-25)30-17-9-11-28-12-10-17/h3-13H,14H2,1-2H3,(H,28,29,30,31) ABAAXOFNHJTHQI-UHFFFAOYSA-N 378985 2-[1-(2,3- difluoro-4- methylbenzyl)- 1H-indazol-3-yl]- 5-methoxy-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 2-8-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 6.70 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378985 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378985&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71553262 404338979 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757125 COc1cnc(nc1N(Cc1ccc(C)c(F)c1F)c1ccncc1)-c1nn(Cc2ccc(C)c(F)c2F)c2ccccc12 InChI=1S/C33H26F4N6O/c1-19-8-10-21(29(36)27(19)34)17-42(23-12-14-38-15-13-23)33-26(44-3)16-39-32(40-33)31-24-6-4-5-7-25(24)43(41-31)18-22-11-9-20(2)28(35)30(22)37/h4-16H,17-18H2,1-3H3 JTTNDVKUBBMBSD-UHFFFAOYSA-N 378986 N-(2,3-difluoro- 4-methylbenzyl)- 2-[1-(2,3- difluoro-4- methylbenzyl)- 1H-indazol-3-yl]- 5-methoxy-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 2-8-2 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 290 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378986 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378986&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71553263 404338980 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757126 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2ccc(cc2)-n2cccn2)c2ccccc12 InChI=1S/C27H22N8O/c1-36-24-17-29-27(32-26(24)31-20-11-14-28-15-12-20)25-22-5-2-3-6-23(22)35(33-25)18-19-7-9-21(10-8-19)34-16-4-13-30-34/h2-17H,18H2,1H3,(H,28,29,31,32) SDZZGTGJMBFYHH-UHFFFAOYSA-N 378987 5-methoxy-2- {1-[4-(1H- pyrazol-1- yl)benzyl]-1H- indazol-3-yl}- N-(pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 2-8-3 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 57.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378987 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378987&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71553265 404338981 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757127 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2c(Cl)cccc2Cl)c2ccccc12 InChI=1S/C24H18Cl2N6O/c1-33-21-13-28-24(30-23(21)29-15-9-11-27-12-10-15)22-16-5-2-3-8-20(16)32(31-22)14-17-18(25)6-4-7-19(17)26/h2-13H,14H2,1H3,(H,27,28,29,30) WKVJEUQFHJPHMA-UHFFFAOYSA-N 378988 2-[1-(2,6- dichlorobenzyl)- 1H-indazol-3-yl]- 5-methoxy-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 15-4::US10266548, Example 2-9-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 6.70 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378988 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378988&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71554578 404338982 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757128 COc1cnc(nc1N(Cc1c(Cl)cccc1Cl)c1ccncc1)-c1nn(Cc2c(Cl)cccc2Cl)c2ccccc12 InChI=1S/C31H22Cl4N6O/c1-42-28-16-37-30(29-20-6-2-3-11-27(20)41(39-29)18-22-25(34)9-5-10-26(22)35)38-31(28)40(19-12-14-36-15-13-19)17-21-23(32)7-4-8-24(21)33/h2-16H,17-18H2,1H3 LJTZQLXDVJNPMF-UHFFFAOYSA-N 378989 N-(2,6- dichlorobenzyl)- 2-[1-(2,6- dichlorobenzyl)- 1H-indazol-3-yl]- 5-methoxy-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 2-9-2 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 240 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378989 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378989&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71553356 404338983 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757129 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2ccc(SC(F)(F)F)cc2)c2ccccc12 InChI=1S/C25H19F3N6OS/c1-35-21-14-30-24(32-23(21)31-17-10-12-29-13-11-17)22-19-4-2-3-5-20(19)34(33-22)15-16-6-8-18(9-7-16)36-25(26,27)28/h2-14H,15H2,1H3,(H,29,30,31,32) GQQOQRAWCGVLAY-UHFFFAOYSA-N 378990 5-methoxy-N- (pyridin-4-yl)- 2-(1-{4- [(trifluoromethyl) sulfanyl] benzyl}-1H- indazol-3- yl)pyrimidin-4- amine::US10266548, Example 2-9-3 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 20000 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378990 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378990&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71553357 404338984 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757130 CCOc1cc(F)c(Cn2nc(-c3ncc(O)c(Nc4ccncc4)n3)c3ccccc23)c(F)c1 InChI=1S/C25H20F2N6O2/c1-2-35-16-11-19(26)18(20(27)12-16)14-33-21-6-4-3-5-17(21)23(32-33)25-29-13-22(34)24(31-25)30-15-7-9-28-10-8-15/h3-13,34H,2,14H2,1H3,(H,28,29,30,31) XULWVADMVGBPJU-UHFFFAOYSA-N 378991 Preparation of 2-[1-(4-ethoxy-2,6-difluorobenzyl)-1H-indazol-3-yl]-4-(pyridin-4-ylamino)pyrimidin-5-ol::US10266548, Example 3-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 4.70 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378991 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378991&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 136271309 404338985 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757131 COc1ccc(Cn2nc(-c3ncc(O)c(Nc4ccncc4)n3)c3ccccc23)cc1 InChI=1S/C24H20N6O2/c1-32-18-8-6-16(7-9-18)15-30-20-5-3-2-4-19(20)22(29-30)24-26-14-21(31)23(28-24)27-17-10-12-25-13-11-17/h2-14,31H,15H2,1H3,(H,25,26,27,28) ACMFKSMNPZDMJV-UHFFFAOYSA-N 378992 2-[1-(4- methoxybenzyl)- 1H-indazol- 3-yl]-4-(pyridin- 4-ylamino) pyrimidin-5-ol::US10266548, Example 3-2 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 9.80 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378992 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378992&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 136271303 404338986 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757132 Oc1cnc(nc1Nc1ccncc1)-c1nn(Cc2ccccc2F)c2ccccc12 InChI=1S/C23H17FN6O/c24-18-7-3-1-5-15(18)14-30-19-8-4-2-6-17(19)21(29-30)23-26-13-20(31)22(28-23)27-16-9-11-25-12-10-16/h1-13,31H,14H2,(H,25,26,27,28) OJYXAVOBMIWFTE-UHFFFAOYSA-N 378993 2-[1-(2- fluorobenzyl)- 1H-indazol-3- yl]-4-(pyridin-4- ylamino) pyrimidin-5-ol::US10266548, Example 3-3 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 15.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378993 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378993&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 136271304 404338987 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757133 Oc1cnc(nc1Nc1ccncc1)-c1nn(Cc2ccc(F)cc2)c2ccccc12 InChI=1S/C23H17FN6O/c24-16-7-5-15(6-8-16)14-30-19-4-2-1-3-18(19)21(29-30)23-26-13-20(31)22(28-23)27-17-9-11-25-12-10-17/h1-13,31H,14H2,(H,25,26,27,28) SXLBYSJWTZGJQF-UHFFFAOYSA-N 378994 2-[1-(4- fluorobenzyl)- 1H-indazol-3- yl]-4-(pyridin-4- ylamino) pyrimidin- 5-ol::US10266548, Example 3-4 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 48.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378994 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378994&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 136271310 404338988 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757134 CCOc1cc(F)c(Cn2nc(-c3ncc(OCC4(CO)COC4)c(Nc4ccncc4)n3)c3ccccc23)c(F)c1 InChI=1S/C30H28F2N6O4/c1-2-41-20-11-23(31)22(24(32)12-20)14-38-25-6-4-3-5-21(25)27(37-38)29-34-13-26(42-18-30(15-39)16-40-17-30)28(36-29)35-19-7-9-33-10-8-19/h3-13,39H,2,14-18H2,1H3,(H,33,34,35,36) RPGOUYSZXLYWJE-UHFFFAOYSA-N 378995 Preparation of {3-[({2-[1-(4-ethoxy-2,6-difluorobenzyl)-1H-indazol-3-yl]-4-(pyridin-4-ylamino)pyrimidin-5-yl}oxy)methyl]oxetan-3-yl}methanol::US10266548, Example 4-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 2.40 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378995 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378995&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71554318 404338989 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757135 CCOc1cc(F)c(Cn2nc(-c3ncc(OCCOC)c(Nc4ccncc4)n3)c3ccccc23)c(F)c1 InChI=1S/C28H26F2N6O3/c1-3-38-19-14-22(29)21(23(30)15-19)17-36-24-7-5-4-6-20(24)26(35-36)28-32-16-25(39-13-12-37-2)27(34-28)33-18-8-10-31-11-9-18/h4-11,14-16H,3,12-13,17H2,1-2H3,(H,31,32,33,34) ICVHEPGGGSOAAC-UHFFFAOYSA-N 378996 2-[1-(4-ethoxy- 2,6- difluorobenzyl)- 1H-indazol-3-yl]- 5-(2- methoxyethoxy)- N-(pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 4-10 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 9.00 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378996 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378996&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89488615 404338990 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757136 CCOc1cc(F)c(Cn2nc(-c3ncc(OCC4CN(CCO4)C(=O)OC(C)(C)C)c(Nc4ccncc4)n3)c3ccccc23)c(F)c1 InChI=1S/C35H37F2N7O5/c1-5-46-23-16-27(36)26(28(37)17-23)20-44-29-9-7-6-8-25(29)31(42-44)33-39-18-30(32(41-33)40-22-10-12-38-13-11-22)48-21-24-19-43(14-15-47-24)34(45)49-35(2,3)4/h6-13,16-18,24H,5,14-15,19-21H2,1-4H3,(H,38,39,40,41) JBLNSQGWUGYYLX-UHFFFAOYSA-N 378997 US10266548, Example 4-11::tert-butyl 2-[({2- [1-(4-ethoxy-2,6- difluorobenzyl)- 1H-indazol-3-yl]- 4-(pyridin-4- ylamino) pyrimidin- 5- yl}oxy)methyl] morpholine-4- carboxylate Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 24.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378997 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378997&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89495304 404338991 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757137 CCOc1cc(F)c(Cn2nc(-c3ncc(OCCN4CCOCC4)c(Nc4ccncc4)n3)c3ccccc23)c(F)c1 InChI=1S/C31H31F2N7O3/c1-2-42-22-17-25(32)24(26(33)18-22)20-40-27-6-4-3-5-23(27)29(38-40)31-35-19-28(43-16-13-39-11-14-41-15-12-39)30(37-31)36-21-7-9-34-10-8-21/h3-10,17-19H,2,11-16,20H2,1H3,(H,34,35,36,37) RHVMYHXFKZDMOX-UHFFFAOYSA-N 378998 2-[1-(4-ethoxy- 2,6- difluorobenzyl)- 1H-indazol-3-yl]- 5-[2-(morpholin- 4-yl)ethoxy]-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 4-12 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 7.80 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378998 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378998&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89488611 404338992 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757138 COCc1noc(COc2cnc(nc2Nc2ccncc2)-c2nn(Cc3ccccc3F)c3ccccc23)n1 InChI=1S/C28H23FN8O3/c1-38-16-24-33-25(40-36-24)17-39-23-14-31-28(34-27(23)32-19-10-12-30-13-11-19)26-20-7-3-5-9-22(20)37(35-26)15-18-6-2-4-8-21(18)29/h2-14H,15-17H2,1H3,(H,30,31,32,34) XSFFAXPPGGARNP-UHFFFAOYSA-N 378999 2-[1-(2- fluorobenzyl)- 1H-indazol-3-yl]- 5-{[3- (methoxymethyl)- 1,2,4- oxadiazol-5- yl]methoxy}-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 4-13 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 7.60 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378999 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378999&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89487243 404338993 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757139 CCOC(=O)COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2c(F)cc(OCC)cc2F)c2ccccc12 InChI=1S/C29H26F2N6O4/c1-3-39-19-13-22(30)21(23(31)14-19)16-37-24-8-6-5-7-20(24)27(36-37)29-33-15-25(41-17-26(38)40-4-2)28(35-29)34-18-9-11-32-12-10-18/h5-15H,3-4,16-17H2,1-2H3,(H,32,33,34,35) GYGGJHBAUHCXFT-UHFFFAOYSA-N 379000 US10266548, Example 4-14::ethyl ({2-[1-(4- ethoxy-2,6- difluorobenzyl)- 1H-indazol-3-yl]- 4-(pyridin-4- ylamino) pyrimidin- 5-yl}oxy)acetate Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 12.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379000 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379000&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 90379089 404338994 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757140 CCOc1cc(F)c(Cn2nc(-c3ncc(OCC(=O)N4CC(F)(F)C4)c(Nc4ccncc4)n3)c3ccccc23)c(F)c1 InChI=1S/C30H25F4N7O3/c1-2-43-19-11-22(31)21(23(32)12-19)14-41-24-6-4-3-5-20(24)27(39-41)29-36-13-25(28(38-29)37-18-7-9-35-10-8-18)44-15-26(42)40-16-30(33,34)17-40/h3-13H,2,14-17H2,1H3,(H,35,36,37,38) CEZGPAYQEZWKKE-UHFFFAOYSA-N 379001 1-(3,3- difluoroazetidin- 1-yl)-2-({2-[1-(4- ethoxy-2,6- difluorobenzyl)- 1H-indazol-3-yl]- 4-(pyridin-4- ylamino) pyrimidin- 5- yl}oxy)ethanone::US10266548, Example 4-15 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 8.00 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379001 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379001&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89487565 404338995 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757141 CCOc1cc(F)c(Cn2nc(-c3ncc(OCCSC)c(Nc4ccncc4)n3)c3ccccc23)c(F)c1 InChI=1S/C28H26F2N6O2S/c1-3-37-19-14-22(29)21(23(30)15-19)17-36-24-7-5-4-6-20(24)26(35-36)28-32-16-25(38-12-13-39-2)27(34-28)33-18-8-10-31-11-9-18/h4-11,14-16H,3,12-13,17H2,1-2H3,(H,31,32,33,34) RBLBXVNMLGGPRA-UHFFFAOYSA-N 379002 2-[1-(4-ethoxy- 2,6- difluorobenzyl)- 1H-indazol-3-yl]- 5-[2- (methylsulfanyl) ethoxy]-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 4-16 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 14.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379002 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379002&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 86732468 404338996 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757142 CCOc1cc(F)c(Cn2nc(-c3ncc(OCCOCCO)c(Nc4ccncc4)n3)c3ccccc23)c(F)c1 InChI=1S/C29H28F2N6O4/c1-2-40-20-15-23(30)22(24(31)16-20)18-37-25-6-4-3-5-21(25)27(36-37)29-33-17-26(41-14-13-39-12-11-38)28(35-29)34-19-7-9-32-10-8-19/h3-10,15-17,38H,2,11-14,18H2,1H3,(H,32,33,34,35) BYGQZPGVGFAQKB-UHFFFAOYSA-N 379003 2-[2-({2-[1-(4- ethoxy-2,6- difluorobenzyl)- 1H-indazol-3-yl]- 4-(pyridin-4- ylamino) pyrimidin- 5- yl}oxy)ethoxy] ethanol::US10266548, Example 4-17 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 7.40 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379003 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379003&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89487568 404338997 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757143 CCOc1cc(F)c(Cn2nc(-c3ncc(OC[C@@H]4CCC(=O)N4)c(Nc4ccncc4)n3)c3ccccc23)c(F)c1 InChI=1S/C30H27F2N7O3/c1-2-41-20-13-23(31)22(24(32)14-20)16-39-25-6-4-3-5-21(25)28(38-39)30-34-15-26(42-17-19-7-8-27(40)35-19)29(37-30)36-18-9-11-33-12-10-18/h3-6,9-15,19H,2,7-8,16-17H2,1H3,(H,35,40)(H,33,34,36,37)/t19-/m0/s1 HMTIKOPYGBRZPX-IBGZPJMESA-N 379004 US10266548, Example 4-18::US10266548, Example 4-22::formic acid - (5S)-5-[({2-[1-(4- ethoxy-2,6- difluorobenzyl)- 1H-indazol-3-yl]- 4-(pyridin-4- ylamino) pyrimidin- 5- yl}oxy)methyl] pyrrolidin-2-one (1:1) Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 12.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379004 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379004&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89487396 404338998 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757144 CCOc1cc(F)c(Cn2nc(-c3ncc(OC[C@H]4CCC(=O)N4)c(Nc4ccncc4)n3)c3ccccc23)c(F)c1 InChI=1S/C30H27F2N7O3/c1-2-41-20-13-23(31)22(24(32)14-20)16-39-25-6-4-3-5-21(25)28(38-39)30-34-15-26(42-17-19-7-8-27(40)35-19)29(37-30)36-18-9-11-33-12-10-18/h3-6,9-15,19H,2,7-8,16-17H2,1H3,(H,35,40)(H,33,34,36,37)/t19-/m1/s1 HMTIKOPYGBRZPX-LJQANCHMSA-N 379005 (5R)-5-[({2-[1-(4- ethoxy-2,6- difluorobenzyl)- 1H-indazol-3-yl]- 4-(pyridin-4- ylamino) pyrimidin- 5- yl}oxy)methyl] pyrrolidin-2-one::US10266548, Example 4-19 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 10.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379005 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379005&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89487630 404338999 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757145 OCC1(COc2cnc(nc2Nc2ccncc2)-c2nn(Cc3ccccc3F)c3ccccc23)COC1 InChI=1S/C28H25FN6O3/c29-22-7-3-1-5-19(22)14-35-23-8-4-2-6-21(23)25(34-35)27-31-13-24(38-18-28(15-36)16-37-17-28)26(33-27)32-20-9-11-30-12-10-20/h1-13,36H,14-18H2,(H,30,31,32,33) ONSODMYVNFUUAS-UHFFFAOYSA-N 379006 US10266548, Example 4-2-1::{3[({2-[1-(2- fluorobenzyl)- 1H-indazol-3-yl]- 4-(pyridin-4- ylamino) pyrimidin-5- yl}oxy)methyl] oxetan-3- yl}methanol Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 3.30 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379006 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379006&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71554317 404339000 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757146 OCC1(COc2cnc(nc2N(CC2(CO)COC2)c2ccncc2)-c2nn(Cc3ccccc3F)c3ccccc23)COC1 InChI=1S/C33H33FN6O5/c34-26-7-3-1-5-23(26)14-40-27-8-4-2-6-25(27)29(38-40)30-36-13-28(45-22-33(17-42)20-44-21-33)31(37-30)39(24-9-11-35-12-10-24)15-32(16-41)18-43-19-32/h1-13,41-42H,14-22H2 DSDFDVDFHQPWOH-UHFFFAOYSA-N 379007 (3-{[(2-[1-(2- fluorobenzyl)- 1H-indazol-3-yl]- 5-{[3- (hydroxymethyl) oxetan-3- yl]methoxy} pyrimidin-4- yl)(pyridin-4- yl)amino]methyl} oxetan-3- yl)methanol::US10266548, Example 4-2-2 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 430 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379007 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379007&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89487632 404339001 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757147 NS(=O)(=O)COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2ccccc2F)c2ccccc12 InChI=1S/C24H20FN7O3S/c25-19-7-3-1-5-16(19)14-32-20-8-4-2-6-18(20)22(31-32)24-28-13-21(35-15-36(26,33)34)23(30-24)29-17-9-11-27-12-10-17/h1-13H,14-15H2,(H2,26,33,34)(H,27,28,29,30) IPCRWWAALSOTIB-UHFFFAOYSA-N 379008 US10266548, Example 4-3 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 9.30 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379008 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379008&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71554316 404339002 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757148 CC(C)(C)OC(=O)NCCOCCOc1cnc(nc1Nc1ccncc1)-c1nn(Cc2ccccc2F)c2ccccc12 InChI=1S/C32H34FN7O4/c1-32(2,3)44-31(41)35-16-17-42-18-19-43-27-20-36-30(38-29(27)37-23-12-14-34-15-13-23)28-24-9-5-7-11-26(24)40(39-28)21-22-8-4-6-10-25(22)33/h4-15,20H,16-19,21H2,1-3H3,(H,35,41)(H,34,36,37,38) OPLMLIJXIGPDCM-UHFFFAOYSA-N 379009 US10266548, Example 4-20::tert-butyl {2-[2- ({2-[1-(2- fluorobenzyl)- 1H-indazol-3-yl]- 4-(pyridin-4- ylamino)pyrimidin- 5- yl}oxy)ethoxy] ethyl}carbamate Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 210 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379009 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379009&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 90379091 404339003 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757149 CCOc1cc(F)c(Cn2nc(-c3ncc(OCC(=O)N4CC(F)C4)c(Nc4ccncc4)n3)c3ccccc23)c(F)c1 InChI=1S/C30H26F3N7O3/c1-2-42-20-11-23(32)22(24(33)12-20)16-40-25-6-4-3-5-21(25)28(38-40)30-35-13-26(43-17-27(41)39-14-18(31)15-39)29(37-30)36-19-7-9-34-10-8-19/h3-13,18H,2,14-17H2,1H3,(H,34,35,36,37) HKEWSSHRWGBJEJ-UHFFFAOYSA-N 379010 2-({2-[1-(4- ethoxy-2,6- difluorobenzyl)- 1H-indazol-3-yl]- 4-(pyridin-4- ylamino) pyrimidin- 5-yl}oxy)-1-(3- fiuoroazetidin-1- yl)ethanone::US10266548, Example 4-21 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 7.80 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379010 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379010&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89487470 404339004 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757150 CCOc1cc(F)c(Cn2nc(-c3ncc(OC[C@@H]4CCC(=O)N4)c(Nc4ccncc4)n3)c3ccccc23)c(F)c1 InChI=1S/C30H27F2N7O3/c1-2-41-20-13-23(31)22(24(32)14-20)16-39-25-6-4-3-5-21(25)28(38-39)30-34-15-26(42-17-19-7-8-27(40)35-19)29(37-30)36-18-9-11-33-12-10-18/h3-6,9-15,19H,2,7-8,16-17H2,1H3,(H,35,40)(H,33,34,36,37)/t19-/m0/s1 HMTIKOPYGBRZPX-IBGZPJMESA-N 379004 US10266548, Example 4-18::US10266548, Example 4-22::formic acid - (5S)-5-[({2-[1-(4- ethoxy-2,6- difluorobenzyl)- 1H-indazol-3-yl]- 4-(pyridin-4- ylamino) pyrimidin- 5- yl}oxy)methyl] pyrrolidin-2-one (1:1) Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 5.80 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379004 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379004&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89487396 404338998 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757151 NS(=O)(=O)COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2ccccc2F)c2ccccc12 InChI=1S/C24H20FN7O3S/c25-19-7-3-1-5-16(19)14-32-20-8-4-2-6-18(20)22(31-32)24-28-13-21(35-15-36(26,33)34)23(30-24)29-17-9-11-27-12-10-17/h1-13H,14-15H2,(H2,26,33,34)(H,27,28,29,30) IPCRWWAALSOTIB-UHFFFAOYSA-N 379008 US10266548, Example 4-3 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 7.50 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379008 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379008&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71554316 404339002 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757152 CN(C)CCOc1cnc(nc1Nc1ccncc1)-c1nn(Cc2ccccc2F)c2ccccc12 InChI=1S/C27H26FN7O/c1-34(2)15-16-36-24-17-30-27(32-26(24)31-20-11-13-29-14-12-20)25-21-8-4-6-10-23(21)35(33-25)18-19-7-3-5-9-22(19)28/h3-14,17H,15-16,18H2,1-2H3,(H,29,30,31,32) OJDMEGRZKFGXIX-UHFFFAOYSA-N 379013 5-[2- (dimethyl- amino)ethoxy]-2- [1-(2- fluorobenzyl)- 1H-indazol-3-yl] N-(pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 4-4 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 14.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379013 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379013&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89487481 404339005 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757153 Fc1ccccc1Cn1nc(-c2ncc(OCCc3nnn[nH]3)c(Nc3ccncc3)n2)c2ccccc12 InChI=1S/C26H21FN10O/c27-20-7-3-1-5-17(20)16-37-21-8-4-2-6-19(21)24(34-37)26-29-15-22(38-14-11-23-32-35-36-33-23)25(31-26)30-18-9-12-28-13-10-18/h1-10,12-13,15H,11,14,16H2,(H,28,29,30,31)(H,32,33,35,36) BCSODFJHVCJLQH-UHFFFAOYSA-N 379014 US10266548, Example 4-5 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 18.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379014 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379014&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89495310 404339006 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757154 Fc1ccccc1Cn1nc(-c2ncc(OCCc3nnn[nH]3)c(n2)N(CCc2nnn[nH]2)c2ccncc2)c2ccccc12 InChI=1S/C29H25FN14O/c30-22-7-3-1-5-19(22)18-44-23-8-4-2-6-21(23)27(38-44)28-32-17-24(45-16-12-26-36-41-42-37-26)29(33-28)43(20-9-13-31-14-10-20)15-11-25-34-39-40-35-25/h1-10,13-14,17H,11-12,15-16,18H2,(H,34,35,39,40)(H,36,37,41,42) DLFWLAHAVCHDFG-UHFFFAOYSA-N 379015 2-[1-(2- fluorobenzyl)- 1H-indazol-3-yl]- N-(pyridin-4-yl)- 5-[2-(1H- tetrazol-5- yl)ethoxy]-N-[2- (1H-tetrazol-5- yl)ethyl]pyrimidin- 4-amine::US10266548, Example 4-5-2 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 330 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379015 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379015&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89495327 404339007 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757155 CN(C)CCOc1cnc(nc1Nc1ccncc1)-c1nn(Cc2ccc(F)cc2)c2ccccc12 InChI=1S/C27H26FN7O/c1-34(2)15-16-36-24-17-30-27(32-26(24)31-21-11-13-29-14-12-21)25-22-5-3-4-6-23(22)35(33-25)18-19-7-9-20(28)10-8-19/h3-14,17H,15-16,18H2,1-2H3,(H,29,30,31,32) DSGUCFHRNSVIAF-UHFFFAOYSA-N 379016 5-[2- (dimethyl- amino)ethoxy]-2- [1-(4- ftuorobenzyl)- 1H-indazol-3-yl]- N-(pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 4-6 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 29.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379016 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379016&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89487693 404339008 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757156 Fc1ccccc1Cn1nc(-c2ncc(OCc3nnn[nH]3)c(Nc3ccncc3)n2)c2ccccc12 InChI=1S/C25H19FN10O/c26-19-7-3-1-5-16(19)14-36-20-8-4-2-6-18(20)23(33-36)25-28-13-21(37-15-22-31-34-35-32-22)24(30-25)29-17-9-11-27-12-10-17/h1-13H,14-15H2,(H,27,28,29,30)(H,31,32,34,35) HUQGDJKMRYIGEU-UHFFFAOYSA-N 379017 2-[1-(2- fluorobenzyl)- 1H-indazol-3-yl]- N-(pyridin-4-yl)- 5-(1H-tetrazol-5- ylmethoxy) pyrimidin-4-amine::US10266548, Example 4-7 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 35.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379017 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379017&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 90373594 404339009 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757157 CCOc1cc(F)c(Cn2nc(-c3ncc(OCCN(C)C)c(Nc4ccncc4)n3)c3ccccc23)c(F)c1 InChI=1S/C29H29F2N7O2/c1-4-39-20-15-23(30)22(24(31)16-20)18-38-25-8-6-5-7-21(25)27(36-38)29-33-17-26(40-14-13-37(2)3)28(35-29)34-19-9-11-32-12-10-19/h5-12,15-17H,4,13-14,18H2,1-3H3,(H,32,33,34,35) TVXJMLKHLLERGD-UHFFFAOYSA-N 379018 5-[2- (dimethyl- amino)ethoxy]-2- [1-(4-ethoxy-2,6- difluorobenzyl)- 1H-indazol-3-yl]- N-(pyridin-4~ yl)pyrimidin-4- amine::US10266548, Example 4-8 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 8.00 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379018 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379018&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 90373828 404339010 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757158 CCOc1cc(F)c(Cn2nc(-c3ncc(OCC(O)CN4CCCCC4)c(Nc4ccncc4)n3)c3ccccc23)c(F)c1 InChI=1S/C33H35F2N7O3/c1-2-44-24-16-27(34)26(28(35)17-24)20-42-29-9-5-4-8-25(29)31(40-42)33-37-18-30(32(39-33)38-22-10-12-36-13-11-22)45-21-23(43)19-41-14-6-3-7-15-41/h4-5,8-13,16-18,23,43H,2-3,6-7,14-15,19-21H2,1H3,(H,36,37,38,39) BRELMQSKBQLEDD-UHFFFAOYSA-N 379019 1-({2-[1-(4- ethoxy-2,6- difluorobenzyl)- 1H-indazol-3-yl]- 4-(pyridin-4- ylamino) pyrimidin- 5-yl}oxy)-3- (piperidin-1- yl)propan-2-ol::US10266548, Example 4-9 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 5.40 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379019 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379019&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89495360 404339011 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757159 CCOc1cc(F)c(Cn2nc(-c3ncc(OCCOC)c(Nc4ccncc4)n3)c3ccccc23)c(F)c1 InChI=1S/C28H26F2N6O3/c1-3-38-19-14-22(29)21(23(30)15-19)17-36-24-7-5-4-6-20(24)26(35-36)28-32-16-25(39-13-12-37-2)27(34-28)33-18-8-10-31-11-9-18/h4-11,14-16H,3,12-13,17H2,1-2H3,(H,31,32,33,34) ICVHEPGGGSOAAC-UHFFFAOYSA-N 378996 2-[1-(4-ethoxy- 2,6- difluorobenzyl)- 1H-indazol-3-yl]- 5-(2- methoxyethoxy)- N-(pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 4-10 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 9.00 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378996 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378996&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89488615 404338990 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757160 CCOc1cc(F)c(Cn2nc(-c3ncc(OCC4CN(CCO4)C(=O)OC(C)(C)C)c(Nc4ccncc4)n3)c3ccccc23)c(F)c1 InChI=1S/C35H37F2N7O5/c1-5-46-23-16-27(36)26(28(37)17-23)20-44-29-9-7-6-8-25(29)31(42-44)33-39-18-30(32(41-33)40-22-10-12-38-13-11-22)48-21-24-19-43(14-15-47-24)34(45)49-35(2,3)4/h6-13,16-18,24H,5,14-15,19-21H2,1-4H3,(H,38,39,40,41) JBLNSQGWUGYYLX-UHFFFAOYSA-N 378997 US10266548, Example 4-11::tert-butyl 2-[({2- [1-(4-ethoxy-2,6- difluorobenzyl)- 1H-indazol-3-yl]- 4-(pyridin-4- ylamino) pyrimidin- 5- yl}oxy)methyl] morpholine-4- carboxylate Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 24.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378997 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378997&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89495304 404338991 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757161 CCOc1cc(F)c(Cn2nc(-c3ncc(OCCN4CCOCC4)c(Nc4ccncc4)n3)c3ccccc23)c(F)c1 InChI=1S/C31H31F2N7O3/c1-2-42-22-17-25(32)24(26(33)18-22)20-40-27-6-4-3-5-23(27)29(38-40)31-35-19-28(43-16-13-39-11-14-41-15-12-39)30(37-31)36-21-7-9-34-10-8-21/h3-10,17-19H,2,11-16,20H2,1H3,(H,34,35,36,37) RHVMYHXFKZDMOX-UHFFFAOYSA-N 378998 2-[1-(4-ethoxy- 2,6- difluorobenzyl)- 1H-indazol-3-yl]- 5-[2-(morpholin- 4-yl)ethoxy]-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 4-12 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 7.80 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378998 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378998&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89488611 404338992 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757162 COCc1noc(COc2cnc(nc2Nc2ccncc2)-c2nn(Cc3ccccc3F)c3ccccc23)n1 InChI=1S/C28H23FN8O3/c1-38-16-24-33-25(40-36-24)17-39-23-14-31-28(34-27(23)32-19-10-12-30-13-11-19)26-20-7-3-5-9-22(20)37(35-26)15-18-6-2-4-8-21(18)29/h2-14H,15-17H2,1H3,(H,30,31,32,34) XSFFAXPPGGARNP-UHFFFAOYSA-N 378999 2-[1-(2- fluorobenzyl)- 1H-indazol-3-yl]- 5-{[3- (methoxymethyl)- 1,2,4- oxadiazol-5- yl]methoxy}-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 4-13 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 76.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378999 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378999&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89487243 404338993 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757163 CCOC(=O)COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2c(F)cc(OCC)cc2F)c2ccccc12 InChI=1S/C29H26F2N6O4/c1-3-39-19-13-22(30)21(23(31)14-19)16-37-24-8-6-5-7-20(24)27(36-37)29-33-15-25(41-17-26(38)40-4-2)28(35-29)34-18-9-11-32-12-10-18/h5-15H,3-4,16-17H2,1-2H3,(H,32,33,34,35) GYGGJHBAUHCXFT-UHFFFAOYSA-N 379000 US10266548, Example 4-14::ethyl ({2-[1-(4- ethoxy-2,6- difluorobenzyl)- 1H-indazol-3-yl]- 4-(pyridin-4- ylamino) pyrimidin- 5-yl}oxy)acetate Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 12.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379000 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379000&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 90379089 404338994 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757164 CCOc1cc(F)c(Cn2nc(-c3ncc(OCC(=O)N4CC(F)(F)C4)c(Nc4ccncc4)n3)c3ccccc23)c(F)c1 InChI=1S/C30H25F4N7O3/c1-2-43-19-11-22(31)21(23(32)12-19)14-41-24-6-4-3-5-20(24)27(39-41)29-36-13-25(28(38-29)37-18-7-9-35-10-8-18)44-15-26(42)40-16-30(33,34)17-40/h3-13H,2,14-17H2,1H3,(H,35,36,37,38) CEZGPAYQEZWKKE-UHFFFAOYSA-N 379001 1-(3,3- difluoroazetidin- 1-yl)-2-({2-[1-(4- ethoxy-2,6- difluorobenzyl)- 1H-indazol-3-yl]- 4-(pyridin-4- ylamino) pyrimidin- 5- yl}oxy)ethanone::US10266548, Example 4-15 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 8.00 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379001 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379001&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89487565 404338995 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757165 CCOc1cc(F)c(Cn2nc(-c3ncc(OCCSC)c(Nc4ccncc4)n3)c3ccccc23)c(F)c1 InChI=1S/C28H26F2N6O2S/c1-3-37-19-14-22(29)21(23(30)15-19)17-36-24-7-5-4-6-20(24)26(35-36)28-32-16-25(38-12-13-39-2)27(34-28)33-18-8-10-31-11-9-18/h4-11,14-16H,3,12-13,17H2,1-2H3,(H,31,32,33,34) RBLBXVNMLGGPRA-UHFFFAOYSA-N 379002 2-[1-(4-ethoxy- 2,6- difluorobenzyl)- 1H-indazol-3-yl]- 5-[2- (methylsulfanyl) ethoxy]-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 4-16 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 14.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379002 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379002&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 86732468 404338996 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757166 CCOc1cc(F)c(Cn2nc(-c3ncc(OCCOCCO)c(Nc4ccncc4)n3)c3ccccc23)c(F)c1 InChI=1S/C29H28F2N6O4/c1-2-40-20-15-23(30)22(24(31)16-20)18-37-25-6-4-3-5-21(25)27(36-37)29-33-17-26(41-14-13-39-12-11-38)28(35-29)34-19-7-9-32-10-8-19/h3-10,15-17,38H,2,11-14,18H2,1H3,(H,32,33,34,35) BYGQZPGVGFAQKB-UHFFFAOYSA-N 379003 2-[2-({2-[1-(4- ethoxy-2,6- difluorobenzyl)- 1H-indazol-3-yl]- 4-(pyridin-4- ylamino) pyrimidin- 5- yl}oxy)ethoxy] ethanol::US10266548, Example 4-17 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 7.40 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379003 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379003&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89487568 404338997 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757167 CCOc1cc(F)c(Cn2nc(-c3ncc(OC[C@@H]4CCC(=O)N4)c(Nc4ccncc4)n3)c3ccccc23)c(F)c1 InChI=1S/C30H27F2N7O3/c1-2-41-20-13-23(31)22(24(32)14-20)16-39-25-6-4-3-5-21(25)28(38-39)30-34-15-26(42-17-19-7-8-27(40)35-19)29(37-30)36-18-9-11-33-12-10-18/h3-6,9-15,19H,2,7-8,16-17H2,1H3,(H,35,40)(H,33,34,36,37)/t19-/m0/s1 HMTIKOPYGBRZPX-IBGZPJMESA-N 379004 US10266548, Example 4-18::US10266548, Example 4-22::formic acid - (5S)-5-[({2-[1-(4- ethoxy-2,6- difluorobenzyl)- 1H-indazol-3-yl]- 4-(pyridin-4- ylamino) pyrimidin- 5- yl}oxy)methyl] pyrrolidin-2-one (1:1) Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 12.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379004 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379004&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89487396 404338998 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757168 CCOc1cc(F)c(Cn2nc(-c3ncc(OC[C@H]4CCC(=O)N4)c(Nc4ccncc4)n3)c3ccccc23)c(F)c1 InChI=1S/C30H27F2N7O3/c1-2-41-20-13-23(31)22(24(32)14-20)16-39-25-6-4-3-5-21(25)28(38-39)30-34-15-26(42-17-19-7-8-27(40)35-19)29(37-30)36-18-9-11-33-12-10-18/h3-6,9-15,19H,2,7-8,16-17H2,1H3,(H,35,40)(H,33,34,36,37)/t19-/m1/s1 HMTIKOPYGBRZPX-LJQANCHMSA-N 379005 (5R)-5-[({2-[1-(4- ethoxy-2,6- difluorobenzyl)- 1H-indazol-3-yl]- 4-(pyridin-4- ylamino) pyrimidin- 5- yl}oxy)methyl] pyrrolidin-2-one::US10266548, Example 4-19 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 10.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379005 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379005&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89487630 404338999 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757169 CC(C)(C)OC(=O)NCCOCCOc1cnc(nc1Nc1ccncc1)-c1nn(Cc2ccccc2F)c2ccccc12 InChI=1S/C32H34FN7O4/c1-32(2,3)44-31(41)35-16-17-42-18-19-43-27-20-36-30(38-29(27)37-23-12-14-34-15-13-23)28-24-9-5-7-11-26(24)40(39-28)21-22-8-4-6-10-25(22)33/h4-15,20H,16-19,21H2,1-3H3,(H,35,41)(H,34,36,37,38) OPLMLIJXIGPDCM-UHFFFAOYSA-N 379009 US10266548, Example 4-20::tert-butyl {2-[2- ({2-[1-(2- fluorobenzyl)- 1H-indazol-3-yl]- 4-(pyridin-4- ylamino)pyrimidin- 5- yl}oxy)ethoxy] ethyl}carbamate Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 210 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379009 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379009&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 90379091 404339003 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757170 CCOc1cc(F)c(Cn2nc(-c3ncc(OCC(=O)N4CC(F)C4)c(Nc4ccncc4)n3)c3ccccc23)c(F)c1 InChI=1S/C30H26F3N7O3/c1-2-42-20-11-23(32)22(24(33)12-20)16-40-25-6-4-3-5-21(25)28(38-40)30-35-13-26(43-17-27(41)39-14-18(31)15-39)29(37-30)36-19-7-9-34-10-8-19/h3-13,18H,2,14-17H2,1H3,(H,34,35,36,37) HKEWSSHRWGBJEJ-UHFFFAOYSA-N 379010 2-({2-[1-(4- ethoxy-2,6- difluorobenzyl)- 1H-indazol-3-yl]- 4-(pyridin-4- ylamino) pyrimidin- 5-yl}oxy)-1-(3- fiuoroazetidin-1- yl)ethanone::US10266548, Example 4-21 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 7.80 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379010 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379010&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89487470 404339004 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757171 CCOc1cc(F)c(Cn2nc(-c3ncc(OC[C@@H]4CCC(=O)N4)c(Nc4ccncc4)n3)c3ccccc23)c(F)c1 InChI=1S/C30H27F2N7O3/c1-2-41-20-13-23(31)22(24(32)14-20)16-39-25-6-4-3-5-21(25)28(38-39)30-34-15-26(42-17-19-7-8-27(40)35-19)29(37-30)36-18-9-11-33-12-10-18/h3-6,9-15,19H,2,7-8,16-17H2,1H3,(H,35,40)(H,33,34,36,37)/t19-/m0/s1 HMTIKOPYGBRZPX-IBGZPJMESA-N 379004 US10266548, Example 4-18::US10266548, Example 4-22::formic acid - (5S)-5-[({2-[1-(4- ethoxy-2,6- difluorobenzyl)- 1H-indazol-3-yl]- 4-(pyridin-4- ylamino) pyrimidin- 5- yl}oxy)methyl] pyrrolidin-2-one (1:1) Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 5.80 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379004 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379004&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89487396 404338998 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757172 CCOc1cc(F)c(Cn2nc(-c3ncc(OCCNC(=O)OC(C)(C)C)c(Nc4ccncc4)n3)c3ccccc23)c(F)c1 InChI=1S/C32H33F2N7O4/c1-5-43-21-16-24(33)23(25(34)17-21)19-41-26-9-7-6-8-22(26)28(40-41)30-37-18-27(29(39-30)38-20-10-12-35-13-11-20)44-15-14-36-31(42)45-32(2,3)4/h6-13,16-18H,5,14-15,19H2,1-4H3,(H,36,42)(H,35,37,38,39) CRVRDHNUDKQGCW-UHFFFAOYSA-N 379020 US10266548, Example 4-23::tert-butyl [2-({2- [1-(4-ethoxy-2,6- difluorobenzyl)- 1H-indazol-3-yl]- 4-(pyridin-4- ylamino) pyrimidin- 5- yl}oxy)ethyl] carbamate Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 9.30 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379020 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379020&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 86732469 404339012 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757173 CCOc1cc(F)c(Cn2nc(-c3nccc(Nc4ccncc4)n3)c3ccccc23)c(F)c1 InChI=1S/C25H20F2N6O/c1-2-34-17-13-20(26)19(21(27)14-17)15-33-22-6-4-3-5-18(22)24(32-33)25-29-12-9-23(31-25)30-16-7-10-28-11-8-16/h3-14H,2,15H2,1H3,(H,28,29,30,31) QBIIUPDGEQMXSD-UHFFFAOYSA-N 379021 Preparation of 2-[1-(4-ethoxy-2,6-difluorobenzyl)-1H-indazol-3-yl]-N-(pyridin-4-yl)pyrimidin-4-amine::US10266548, Example 5-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 5.20 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379021 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379021&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 86732434 404339013 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757174 COc1ccc(Cn2nc(-c3nccc(Nc4ccncc4)n3)c3ccccc23)cc1 InChI=1S/C24H20N6O/c1-31-19-8-6-17(7-9-19)16-30-21-5-3-2-4-20(21)23(29-30)24-26-15-12-22(28-24)27-18-10-13-25-14-11-18/h2-15H,16H2,1H3,(H,25,26,27,28) AKHGAOSWYIFKNV-UHFFFAOYSA-N 379022 2-[1-(4- methoxybenzyl)- 1H- indazol-3-yl]-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 5-2 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 27.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379022 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379022&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89487698 404339014 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757175 Fc1ccccc1Cn1nc(-c2nccc(Nc3ccncc3)n2)c2ccccc12 InChI=1S/C23H17FN6/c24-19-7-3-1-5-16(19)15-30-20-8-4-2-6-18(20)22(29-30)23-26-14-11-21(28-23)27-17-9-12-25-13-10-17/h1-14H,15H2,(H,25,26,27,28) KMFSQXJKUFEDKR-UHFFFAOYSA-N 379023 2-[1-(2- fluorobenzyl)- 1H-indazol-3- yl]-N-(pyridin- 4-yl)pyrimidin- 4-amine::US10266548, Example 5-3 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 28.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379023 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379023&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89487433 404339015 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757176 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2c(F)cc(cc2F)C2CC2)c2ccccc12 InChI=1S/C27H22F2N6O/c1-36-24-14-31-27(33-26(24)32-18-8-10-30-11-9-18)25-19-4-2-3-5-23(19)35(34-25)15-20-21(28)12-17(13-22(20)29)16-6-7-16/h2-5,8-14,16H,6-7,15H2,1H3,(H,30,31,32,33) BSVZTHQKGPELJW-UHFFFAOYSA-N 379024 Preparation of 2-[1-(4-cyclopropyl-2,6-difluorobenzyl)-1H-indazol-3-yl]-5-methoxy-N-(pyridin-4-yl)pyrimidin-4-amine::US10266548, Example 6-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 3.90 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379024 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379024&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 86732436 404339016 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757177 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2c(F)cc(\C=C\C)cc2F)c2ccccc12 InChI=1S/C27H22F2N6O/c1-3-6-17-13-21(28)20(22(29)14-17)16-35-23-8-5-4-7-19(23)25(34-35)27-31-15-24(36-2)26(33-27)32-18-9-11-30-12-10-18/h3-15H,16H2,1-2H3,(H,30,31,32,33)/b6-3+ VUWSGFLVLVWWCD-ZZXKWVIFSA-N 379025 2-(1-{2,6-difluoro- 4-[(1E)-prop-1-en- 1-yl]benzyl}-1H- indazol-3-yl)-5- methoxy-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 6-2 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 7.40 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379025 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379025&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89488612 404339017 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757178 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2c(F)cc(cc2F)C(C)=O)c2ccccc12 InChI=1S/C26H20F2N6O2/c1-15(35)16-11-20(27)19(21(28)12-16)14-34-22-6-4-3-5-18(22)24(33-34)26-30-13-23(36-2)25(32-26)31-17-7-9-29-10-8-17/h3-13H,14H2,1-2H3,(H,29,30,31,32) SSCOALSJVDHZOY-UHFFFAOYSA-N 379026 Preparation of 1-[3,5-difluoro-4-({3-[5-methoxy-4-(pyridin-4-ylamino)pyrimidin-2-yl]-1H-indazol-1-yl}methyl)phenyl]ethanone::US10266548, Example 7-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 3.00 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379026 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379026&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 86732438 404339018 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757179 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2c(Cl)ccc(CO)c2Cl)c2ccccc12 InChI=1S/C25H20Cl2N6O2/c1-35-21-12-29-25(31-24(21)30-16-8-10-28-11-9-16)23-17-4-2-3-5-20(17)33(32-23)13-18-19(26)7-6-15(14-34)22(18)27/h2-12,34H,13-14H2,1H3,(H,28,29,30,31) JDDSLAAWMGQOSG-UHFFFAOYSA-N 379027 Preparation of [2,4-dichloro-3-({3-[5-methoxy-4-(pyridin-4-ylamino)pyrimidin-2-yl]-1H-indazol-1-yl}methyl)phenyl]methanol::US10266548, Example 15-5::US10266548, Example 8-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 7.40 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379027 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379027&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 86732439 404339019 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757180 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2cccc(CCO)c2)c2ccccc12 InChI=1S/C26H24N6O2/c1-34-23-16-28-26(30-25(23)29-20-9-12-27-13-10-20)24-21-7-2-3-8-22(21)32(31-24)17-19-6-4-5-18(15-19)11-14-33/h2-10,12-13,15-16,33H,11,14,17H2,1H3,(H,27,28,29,30) CMAMYQMHNLOZPW-UHFFFAOYSA-N 379028 2-[3-({3-[5-methoxy-4- (pyridin-4- ylamino)pyrimidin-2-yl]- 1H-indazol-1- yl}methyl)phenyl] ethanol::US10266548, Example 8-2 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 21.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379028 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379028&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89487749 404339020 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757181 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2cccc(c2)C(C)(C)CO)c2ccccc12 InChI=1S/C28H28N6O2/c1-28(2,18-35)20-8-6-7-19(15-20)17-34-23-10-5-4-9-22(23)25(33-34)27-30-16-24(36-3)26(32-27)31-21-11-13-29-14-12-21/h4-16,35H,17-18H2,1-3H3,(H,29,30,31,32) XSVUFWMRONGKJI-UHFFFAOYSA-N 379029 2-[3-({3-[5-methoxy-4- (pyridin-4- ylamino)pyrimidin-2-yl]- 1H-indazol-1- yl}methyl)phenyl]-2- methylpropan-1-ol::US10266548, Example 8-3 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 240 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379029 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379029&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89487581 404339021 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757182 CCOc1cc(F)c(Cn2nc(-c3ncc(OC)c(Nc4ccncc4CO)n3)c3ccccc23)c(F)c1 InChI=1S/C27H24F2N6O3/c1-3-38-17-10-20(28)19(21(29)11-17)14-35-23-7-5-4-6-18(23)25(34-35)27-31-13-24(37-2)26(33-27)32-22-8-9-30-12-16(22)15-36/h4-13,36H,3,14-15H2,1-2H3,(H,30,31,32,33) SMODROLJRAPYPO-UHFFFAOYSA-N 379030 US10266548, Example 8-4::[4-({2-[1-(4-ethoxy-2,6- difluorobenzyl)-1H- indazol-3-yl]-5- methoxypyrimidin-4- yl}amino)pyrimidin-3- yl]methanol Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 13.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379030 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379030&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89487463 404339022 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757183 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2ccc(cc2Cl)C(C)(C)O)c2ccccc12 InChI=1S/C27H25ClN6O2/c1-27(2,35)18-9-8-17(21(28)14-18)16-34-22-7-5-4-6-20(22)24(33-34)26-30-15-23(36-3)25(32-26)31-19-10-12-29-13-11-19/h4-15,35H,16H2,1-3H3,(H,29,30,31,32) STVKTLTXBZYDFT-UHFFFAOYSA-N 379031 Preparation of 2-[3-chloro-4-({3-[5-methoxy-4-(pyridin-4-ylamino)pyrimidin-2-yl]-1H-indazol-1-yl}methyl)phenyl]propan-2-ol::US10266548, Example 9-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 9.80 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379031 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379031&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89487717 404339023 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757184 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2cccc(CC(C)(C)O)c2)c2ccccc12 InChI=1S/C28H28N6O2/c1-28(2,35)16-19-7-6-8-20(15-19)18-34-23-10-5-4-9-22(23)25(33-34)27-30-17-24(36-3)26(32-27)31-21-11-13-29-14-12-21/h4-15,17,35H,16,18H2,1-3H3,(H,29,30,31,32) IGRHWTIISTXKQS-UHFFFAOYSA-N 379032 1-[3-({3-[5- methoxy-4- (pyridin-4- ylamino)pyrimidin- 2-yl]-1H-indazol-1- yl}methyl)phenyl]- 2-methylpropan-2- ol::US10266548, Example 9-2 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 21.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379032 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379032&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89487496 404339024 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757185 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2c(Cl)ccc(c2Cl)C(C)(C)O)c2ccccc12 InChI=1S/C27H24Cl2N6O2/c1-27(2,36)19-8-9-20(28)18(23(19)29)15-35-21-7-5-4-6-17(21)24(34-35)26-31-14-22(37-3)25(33-26)32-16-10-12-30-13-11-16/h4-14,36H,15H2,1-3H3,(H,30,31,32,33) CXQUQWTYKPPBHZ-UHFFFAOYSA-N 379033 2-[2,4-dichloro-3- ({3-[5-methoxy-4- (pyridin-4- ylamino)pyrimidin- 2-yl]-1H-indazol-1- yl}methyl)phenyl] propan-2-ol::US10266548, Example 9-3 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 23.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379033 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379033&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89488616 404339025 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757186 CCOc1cc(F)c(Cn2nc(-c3ncc(OC(F)F)c(Cc4ccncc4)n3)c3ccccc23)c(F)c1 InChI=1S/C27H21F4N5O2/c1-2-37-17-12-20(28)19(21(29)13-17)15-36-23-6-4-3-5-18(23)25(35-36)26-33-14-24(38-27(30)31)22(34-26)11-16-7-9-32-10-8-16/h3-10,12-14,27H,2,11,15H2,1H3 VDGLGFBTFDLQJV-UHFFFAOYSA-N 379034 Preparation of 5-(difluoromethoxy)-2-[1-(4-ethoxy-2,6-difluorobenzyl)-1H-indazol-3-yl]-N-(pyridin-4 yl)pyrimidin-4-amine::US10266548, Example 10-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 12.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379034 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379034&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 130417035 404339026 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757187 CCOc1cc(F)c(Cn2nc(-c3ncc(OC(F)F)c(n3)N(C(F)F)c3ccncc3)c3ccccc23)c(F)c1 InChI=1S/C27H20F6N6O2/c1-2-40-16-11-19(28)18(20(29)12-16)14-38-21-6-4-3-5-17(21)23(37-38)24-35-13-22(41-27(32)33)25(36-24)39(26(30)31)15-7-9-34-10-8-15/h3-13,26-27H,2,14H2,1H3 DKRYEECKCUFJNN-UHFFFAOYSA-N 379035 5- (difluoromethoxy)- oxy)-N- (difluoromethyl)- 2-[1-(4-ethoxy- 2,6- difluorobenzyl)- 1H-indazol-3-yl]- N-(pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 10-2 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 420 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379035 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379035&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89495342 404339027 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757188 CCOc1cc(F)c(Cn2nc(-c3ncc(O)c(n3)N(C(F)F)c3ccncc3)c3ccccc23)c(F)c1 InChI=1S/C26H20F4N6O2/c1-2-38-16-11-19(27)18(20(28)12-16)14-35-21-6-4-3-5-17(21)23(34-35)24-32-13-22(37)25(33-24)36(26(29)30)15-7-9-31-10-8-15/h3-13,26,37H,2,14H2,1H3 XUFAATLGNPDZGI-UHFFFAOYSA-N 379036 4- [(difluoromethyl) (pyridin-4- yl)amino]-2-[1-(4- ethoxy-2,6- difluorobenzyl)- 1H-indazol-3- yl]pyrimidin-5-ol::US10266548, Example 10-3 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 360 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379036 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379036&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 136506172 404339028 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757189 COc1ccc(Cn2nc(-c3ncc(OCC(F)(F)F)c(Nc4ccncc4)n3)c3ccccc23)cc1 InChI=1S/C26H21F3N6O2/c1-36-19-8-6-17(7-9-19)15-35-21-5-3-2-4-20(21)23(34-35)25-31-14-22(37-16-26(27,28)29)24(33-25)32-18-10-12-30-13-11-18/h2-14H,15-16H2,1H3,(H,30,31,32,33) GUJXAQIBCNRTSK-UHFFFAOYSA-N 379037 Preparation of 2-[1-(4-methoxybenzyl)-1H-indazol-3-yl]-N-(pyridin-4-yl)-5-(2,2,2-trifluoroethoxy)pyrimidin-4-amine::US10266548, Example 11-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 18.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379037 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379037&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 86732441 404339029 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757190 CCOc1cc(F)c(Cn2nc(-c3ncc(OCC(F)(F)F)c(Nc4ccncc4)n3)c3ccccc23)c(F)c1 InChI=1S/C27H21F5N6O2/c1-2-39-17-11-20(28)19(21(29)12-17)14-38-22-6-4-3-5-18(22)24(37-38)26-34-13-23(40-15-27(30,31)32)25(36-26)35-16-7-9-33-10-8-16/h3-13H,2,14-15H2,1H3,(H,33,34,35,36) SAKGWMPCSFXOGR-UHFFFAOYSA-N 379038 2-[1-(4-ethoxy-2,6- difluorobenzyl)-1H- indazol-3-yl]-N- (pyridin-4-yl)-5- (2,2,2- trifluoroethoxy) pyrimidin-4- amine::US10266548, Example 11-2 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 10.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379038 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379038&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89495299 404339030 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757191 OCC(O)COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2ccccc2F)c2ccccc12 InChI=1S/C26H23FN6O3/c27-21-7-3-1-5-17(21)14-33-22-8-4-2-6-20(22)24(32-33)26-29-13-23(36-16-19(35)15-34)25(31-26)30-18-9-11-28-12-10-18/h1-13,19,34-35H,14-16H2,(H,28,29,30,31) CEZYPMPGLWJWNA-UHFFFAOYSA-N 379039 Preparation of 3-({2-[1-(2-fluorobenzyl)-1H-indazol-3-yl]-4-(pyridin-4-ylamino)-pyrimidin-5-yl}oxy)propane-1,2-diol::US10266548, Example 12-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 11.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379039 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379039&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 86732442 404339031 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757192 OC[C@@H](O)COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2ccccc2F)c2ccccc12 InChI=1S/C26H23FN6O3/c27-21-7-3-1-5-17(21)14-33-22-8-4-2-6-20(22)24(32-33)26-29-13-23(36-16-19(35)15-34)25(31-26)30-18-9-11-28-12-10-18/h1-13,19,34-35H,14-16H2,(H,28,29,30,31)/t19-/m1/s1 CEZYPMPGLWJWNA-LJQANCHMSA-N 379040 Preparation of (2R)-3-({2-[1-(2-fluorobenzyl)-1H-indazol-3-yl]-4-(pyridin-4-ylamino)pyrimidin-5-yl}oxy)propane-1,2-diol::US10266548, Example 12-2::US10266548, Example 15-6 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 4.60 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379040 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379040&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 86732444 404339032 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757193 OC[C@H](O)COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2ccccc2F)c2ccccc12 InChI=1S/C26H23FN6O3/c27-21-7-3-1-5-17(21)14-33-22-8-4-2-6-20(22)24(32-33)26-29-13-23(36-16-19(35)15-34)25(31-26)30-18-9-11-28-12-10-18/h1-13,19,34-35H,14-16H2,(H,28,29,30,31)/t19-/m0/s1 CEZYPMPGLWJWNA-IBGZPJMESA-N 379041 (2S)-3-({2-[1-(2- fluorobenzyl)- 1H-indazol-3-yl]- 4-(pyridin-4- ylamino) pyrimidin- 5- yl}oxy)propane- 1,2-diol::US10266548, Example 12-3::US10266548, Example 15-2 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 4.80 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379041 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379041&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89487399 404339033 C02773 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757194 CCOc1cc(F)c(Cn2nc(-c3ncc(OCCO)c(Nc4ccncc4)n3)c3ccccc23)c(F)c1 InChI=1S/C27H24F2N6O3/c1-2-37-18-13-21(28)20(22(29)14-18)16-35-23-6-4-3-5-19(23)25(34-35)27-31-15-24(38-12-11-36)26(33-27)32-17-7-9-30-10-8-17/h3-10,13-15,36H,2,11-12,16H2,1H3,(H,30,31,32,33) CRBUEAPRYNAYDN-UHFFFAOYSA-N 379042 Preparation of 2-({2-[1-(4-ethoxy-2,6-difluorobenzyl)-1H-indazol-3-yl]-4-(pyridin-4-ylamino)pyrimidin-5-yl}oxy)ethanol::US10266548, Example 13-1::US10266548, Example 15-3 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 3.30 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379042 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379042&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89487393 404339034 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757195 OCCOc1cnc(nc1Nc1ccncc1)-c1nn(Cc2ccccc2F)c2ccccc12 InChI=1S/C25H21FN6O2/c26-20-7-3-1-5-17(20)16-32-21-8-4-2-6-19(21)23(31-32)25-28-15-22(34-14-13-33)24(30-25)29-18-9-11-27-12-10-18/h1-12,15,33H,13-14,16H2,(H,27,28,29,30) SFPNOAKQBIIDHK-UHFFFAOYSA-N 379043 2-({2-[1-(2- fluorobenzyl)- 1H-indazol-3-yl]- 4-(pyridin-4- ylamino) pyrimidin- 5-yl}oxy)ethanol::US10266548, Example 13-2 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 7.20 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379043 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379043&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89487456 404339035 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757196 CCOC(=O)c1cnccc1Nc1nc(ncc1OCCO)-c1nn(Cc2ccccc2F)c2ccccc12 InChI=1S/C28H25FN6O4/c1-2-38-28(37)20-15-30-12-11-22(20)32-26-24(39-14-13-36)16-31-27(33-26)25-19-8-4-6-10-23(19)35(34-25)17-18-7-3-5-9-21(18)29/h3-12,15-16,36H,2,13-14,17H2,1H3,(H,30,31,32,33) PEJGXLDFYGMWQT-UHFFFAOYSA-N 379044 US10266548, Example 13-3::ethyl 4-({2-[1-(2- fluorobenzyl)- 1H-indazol-3-yl]- 5-(2- hydroxyethoxy) pyrimidin-4- yl}amino)pyridine- 3-carboxylate Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 17.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379044 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379044&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89487781 404339036 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757197 CNC(=O)c1cnccc1Nc1nc(ncc1OCCO)-c1nn(Cc2ccccc2F)c2ccccc12 InChI=1S/C27H24FN7O3/c1-29-27(37)19-14-30-11-10-21(19)32-25-23(38-13-12-36)15-31-26(33-25)24-18-7-3-5-9-22(18)35(34-24)16-17-6-2-4-8-20(17)28/h2-11,14-15,36H,12-13,16H2,1H3,(H,29,37)(H,30,31,32,33) IZSVOKJQEMQOTK-UHFFFAOYSA-N 379045 4-({2-[1-(2- fluorobenzyl)- 1H-indazol-3-yl]- 5-(2- hydroxyethoxy)- pyrimidin-4- yl}amino)-N- methylpyridine- 3-carboxamide::US10266548, Example 13-4 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 4.70 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379045 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379045&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89487541 404339037 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757198 NC(=O)c1cnccc1Nc1nc(ncc1OCCO)-c1nn(Cc2ccccc2F)c2ccccc12 InChI=1S/C26H22FN7O3/c27-19-7-3-1-5-16(19)15-34-21-8-4-2-6-17(21)23(33-34)26-30-14-22(37-12-11-35)25(32-26)31-20-9-10-29-13-18(20)24(28)36/h1-10,13-14,35H,11-12,15H2,(H2,28,36)(H,29,30,31,32) SMDQWFRSTBPJBD-UHFFFAOYSA-N 379046 4-({2-[1-(2- fluorobenzyl)- 1H-indazol-3-yl]- 5-(2- hydroxyethoxy) pyrimidin-4- yl}amino)pyridine- 3-carboxamide::US10266548, Example 13-5 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 6.50 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379046 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379046&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89487620 404339038 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757199 OCCOC(=O)c1cnccc1Nc1nc(ncc1OCCO)-c1nn(Cc2ccccc2F)c2ccccc12 InChI=1S/C28H25FN6O5/c29-21-7-3-1-5-18(21)17-35-23-8-4-2-6-19(23)25(34-35)27-31-16-24(39-13-11-36)26(33-27)32-22-9-10-30-15-20(22)28(38)40-14-12-37/h1-10,15-16,36-37H,11-14,17H2,(H,30,31,32,33) PLUUIRBVCCMJNA-UHFFFAOYSA-N 379047 2-hydroxyethyl 4-({2-[1-(2- fluorobenzyl)- 1H-indazol-3-yl]- 5-(2- hydroxyethoxy) pyrimidin-4- yl}amino)pyridine- 3-carboxylate::US10266548, Example 13-6 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 8.60 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379047 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379047&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89487355 404339039 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757200 COc1ccc(Cn2nc(-c3ncc(OC4CC4)c(Nc4ccncc4)n3)c3ccccc23)cc1 InChI=1S/C27H24N6O2/c1-34-20-8-6-18(7-9-20)17-33-23-5-3-2-4-22(23)25(32-33)27-29-16-24(35-21-10-11-21)26(31-27)30-19-12-14-28-15-13-19/h2-9,12-16,21H,10-11,17H2,1H3,(H,28,29,30,31) JALFYGLWDDGNBP-UHFFFAOYSA-N 379048 Preparation of 5-(cyclopropyloxy)-2-[1-(4-methoxybenzyl)-1H-indazol-3-yl]-N-(pyridin-4-yl)pyrimidin-4-amine::US10266548, Example 14-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 3300 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379048 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379048&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 86732446 404339040 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757201 CCOc1cc(F)c(Cn2nc(-c3ncc(OC)c(Nc4ccncc4)n3)c3ccccc23)c(F)c1 InChI=1S/C26H22F2N6O2/c1-3-36-17-12-20(27)19(21(28)13-17)15-34-22-7-5-4-6-18(22)24(33-34)26-30-14-23(35-2)25(32-26)31-16-8-10-29-11-9-16/h4-14H,3,15H2,1-2H3,(H,29,30,31,32) XLJLAZDKCHDNJX-UHFFFAOYSA-N 379049 Preparation of 2-[1-(4-ethoxy-2,6-difluorobenzyl)-1H-indazol-3-yl]-5-methoxy-N-(pyridin-4-yl)pyrimidin-4-amine hydrochloride (1:1)::US10266548, Example 15-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 5.20 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379049 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379049&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 86732433 404339041 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757202 OC[C@H](O)COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2ccccc2F)c2ccccc12 InChI=1S/C26H23FN6O3/c27-21-7-3-1-5-17(21)14-33-22-8-4-2-6-20(22)24(32-33)26-29-13-23(36-16-19(35)15-34)25(31-26)30-18-9-11-28-12-10-18/h1-13,19,34-35H,14-16H2,(H,28,29,30,31)/t19-/m0/s1 CEZYPMPGLWJWNA-IBGZPJMESA-N 379041 (2S)-3-({2-[1-(2- fluorobenzyl)- 1H-indazol-3-yl]- 4-(pyridin-4- ylamino) pyrimidin- 5- yl}oxy)propane- 1,2-diol::US10266548, Example 12-3::US10266548, Example 15-2 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 5.50 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379041 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379041&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89487399 404339033 C02773 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757203 CCOc1cc(F)c(Cn2nc(-c3ncc(OCCO)c(Nc4ccncc4)n3)c3ccccc23)c(F)c1 InChI=1S/C27H24F2N6O3/c1-2-37-18-13-21(28)20(22(29)14-18)16-35-23-6-4-3-5-19(23)25(34-35)27-31-15-24(38-12-11-36)26(33-27)32-17-7-9-30-10-8-17/h3-10,13-15,36H,2,11-12,16H2,1H3,(H,30,31,32,33) CRBUEAPRYNAYDN-UHFFFAOYSA-N 379042 Preparation of 2-({2-[1-(4-ethoxy-2,6-difluorobenzyl)-1H-indazol-3-yl]-4-(pyridin-4-ylamino)pyrimidin-5-yl}oxy)ethanol::US10266548, Example 13-1::US10266548, Example 15-3 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 5.70 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379042 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379042&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89487393 404339034 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757204 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2c(Cl)cccc2Cl)c2ccccc12 InChI=1S/C24H18Cl2N6O/c1-33-21-13-28-24(30-23(21)29-15-9-11-27-12-10-15)22-16-5-2-3-8-20(16)32(31-22)14-17-18(25)6-4-7-19(17)26/h2-13H,14H2,1H3,(H,27,28,29,30) WKVJEUQFHJPHMA-UHFFFAOYSA-N 378988 2-[1-(2,6- dichlorobenzyl)- 1H-indazol-3-yl]- 5-methoxy-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 15-4::US10266548, Example 2-9-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 7.30 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378988 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378988&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71554578 404338982 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757205 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2c(Cl)ccc(CO)c2Cl)c2ccccc12 InChI=1S/C25H20Cl2N6O2/c1-35-21-12-29-25(31-24(21)30-16-8-10-28-11-9-16)23-17-4-2-3-5-20(17)33(32-23)13-18-19(26)7-6-15(14-34)22(18)27/h2-12,34H,13-14H2,1H3,(H,28,29,30,31) JDDSLAAWMGQOSG-UHFFFAOYSA-N 379027 Preparation of [2,4-dichloro-3-({3-[5-methoxy-4-(pyridin-4-ylamino)pyrimidin-2-yl]-1H-indazol-1-yl}methyl)phenyl]methanol::US10266548, Example 15-5::US10266548, Example 8-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 12.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379027 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379027&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 86732439 404339019 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757206 OC[C@@H](O)COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2ccccc2F)c2ccccc12 InChI=1S/C26H23FN6O3/c27-21-7-3-1-5-17(21)14-33-22-8-4-2-6-20(22)24(32-33)26-29-13-23(36-16-19(35)15-34)25(31-26)30-18-9-11-28-12-10-18/h1-13,19,34-35H,14-16H2,(H,28,29,30,31)/t19-/m1/s1 CEZYPMPGLWJWNA-LJQANCHMSA-N 379040 Preparation of (2R)-3-({2-[1-(2-fluorobenzyl)-1H-indazol-3-yl]-4-(pyridin-4-ylamino)pyrimidin-5-yl}oxy)propane-1,2-diol::US10266548, Example 12-2::US10266548, Example 15-6 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 4.60 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379040 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379040&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 86732444 404339032 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757207 CCOc1cc(F)c(Cn2nc(-c3nccc(n3)N(C(C)=O)c3ccncc3)c3ccccc23)c(F)c1 InChI=1S/C27H22F2N6O2/c1-3-37-19-14-22(28)21(23(29)15-19)16-34-24-7-5-4-6-20(24)26(33-34)27-31-13-10-25(32-27)35(17(2)36)18-8-11-30-12-9-18/h4-15H,3,16H2,1-2H3 QYFDOMPSXUHFOK-UHFFFAOYSA-N 379055 Preparation of N-{2-[1-(4-ethoxy-2,6-difluorobenzyl)-1H-indazol-3-yl]pyrimidin-4-yl}-N-(pyridin-4-yl)acetamide::US10266548, Example 16-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 170 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379055 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379055&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 86732448 404339042 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757208 CCOc1cc(F)c(Cn2nc(-c3nccc(n3)N(C(=O)COC)c3ccncc3)c3ccccc23)c(F)c1 InChI=1S/C28H24F2N6O3/c1-3-39-19-14-22(29)21(23(30)15-19)16-35-24-7-5-4-6-20(24)27(34-35)28-32-13-10-25(33-28)36(26(37)17-38-2)18-8-11-31-12-9-18/h4-15H,3,16-17H2,1-2H3 WUABGMMCIVANAE-UHFFFAOYSA-N 379056 N-{2-[1-(4- ethoxy-2,6- difluorobenzyl)- 1H-indazol-3- yl]pyrimidin-4- yl}-2-methoxy- N-(pyridin-4- yl)acetamide::US10266548, Example 16-2 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 23.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379056 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379056&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89487142 404339043 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757209 CCOc1cc(F)c(Cn2nc(-c3nccc(n3)N(C(=O)C3CCOCC3)c3ccncc3)c3ccccc23)c(F)c1 InChI=1S/C31H28F2N6O3/c1-2-42-22-17-25(32)24(26(33)18-22)19-38-27-6-4-3-5-23(27)29(37-38)30-35-14-9-28(36-30)39(21-7-12-34-13-8-21)31(40)20-10-15-41-16-11-20/h3-9,12-14,17-18,20H,2,10-11,15-16,19H2,1H3 BYMOLVWTRRVFBP-UHFFFAOYSA-N 379057 N-{2-[1-(4- ethoxy-2,6- difluorobenzyl)- 1H-indazol-3- yl]pyrimidin-4- yl}-N-(pyridin-4- yl)tetrahydro- 2H-pyran-4- carboxamide::US10266548, Example 16-3 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 210 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379057 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379057&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89487493 404339044 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757210 CCOc1cc(F)c(Cn2nc(-c3nccc(n3)N(C(=O)COCCOC)c3ccncc3)c3ccccc23)c(F)c1 InChI=1S/C30H28F2N6O4/c1-3-42-21-16-24(31)23(25(32)17-21)18-37-26-7-5-4-6-22(26)29(36-37)30-34-13-10-27(35-30)38(20-8-11-33-12-9-20)28(39)19-41-15-14-40-2/h4-13,16-17H,3,14-15,18-19H2,1-2H3 ANBDTCGIVIKIMU-UHFFFAOYSA-N 379058 N-{2-[1-(4- ethoxy-2,6- difluorobenzyl)- 1H-indazol-3- yl]pyrimidin-4- yl}-2-(2- methoxyethoxy) N-(pyridin- 4-yl)acetamide::US10266548, Example 16-4 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 20.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379058 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379058&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89487716 404339045 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757211 CCOc1cc(F)c(Cn2nc(-c3nccc(n3)N(CCO)c3ccncc3)c3ccccc23)c(F)c1 InChI=1S/C27H24F2N6O2/c1-2-37-19-15-22(28)21(23(29)16-19)17-35-24-6-4-3-5-20(24)26(33-35)27-31-12-9-25(32-27)34(13-14-36)18-7-10-30-11-8-18/h3-12,15-16,36H,2,13-14,17H2,1H3 AQLFCBIDRHFZDQ-UHFFFAOYSA-N 379059 Preparation of 2-[{2-[1-(4-ethoxy-2,6-difluorobenzyl)-1H-indazol-3-yl]pyrimidin-4-yl}(pyridin-4-yl)amino]ethanol::US10266548, Example 17-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 170 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379059 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379059&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71554487 404339046 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757212 CCOc1cc(F)c(Cn2nc(-c3nccc(n3)N(CC3(CO)COC3)c3ccncc3)c3ccccc23)c(F)c1 InChI=1S/C30H28F2N6O3/c1-2-41-21-13-24(31)23(25(32)14-21)15-38-26-6-4-3-5-22(26)28(36-38)29-34-12-9-27(35-29)37(20-7-10-33-11-8-20)16-30(17-39)18-40-19-30/h3-14,39H,2,15-19H2,1H3 SIPMTXWEUYEPGF-UHFFFAOYSA-N 379060 (3-{[{(2-[1-(4- ethoxy-2,6- difluorobenzyl)- 1H-indazol-3- yl]pyrimidin-4- yl}(pyridin-4- yl)amino]methyl} oxetan-3- yl)methanol::US10266548, Example 17-2 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 2400 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379060 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379060&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71554581 404339047 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757213 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2c(F)cc(Br)cc2OCC(F)(F)F)c2ccccc12 InChI=1S/C26H19BrF4N6O2/c1-38-22-12-33-25(35-24(22)34-16-6-8-32-9-7-16)23-17-4-2-3-5-20(17)37(36-23)13-18-19(28)10-15(27)11-21(18)39-14-26(29,30)31/h2-12H,13-14H2,1H3,(H,32,33,34,35) XKTISVRIIFTXED-UHFFFAOYSA-N 379061 Preparation of 2-{1-[4-bromo-2-fluoro-6-(2,2,2-trifluoroethoxy)benzyl]-1H-indazol-3-yl}-5-methoxy-N-(pyridin-4-yl)pyrimidin-4-amine::US10266548, Example 18-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 16.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379061 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379061&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 86732449 404339048 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757214 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2c(OCC(F)(F)F)cc(Br)cc2OCC(F)(F)F)c2ccccc12 InChI=1S/C28H21BrF6N6O3/c1-42-23-12-37-26(39-25(23)38-17-6-8-36-9-7-17)24-18-4-2-3-5-20(18)41(40-24)13-19-21(43-14-27(30,31)32)10-16(29)11-22(19)44-15-28(33,34)35/h2-12H,13-15H2,1H3,(H,36,37,38,39) NUJQFJZFZMTHAP-UHFFFAOYSA-N 379062 2-{1-[4-bromo- 2,6-bis(2,2,2- trifluoro- ethoxy)benzyl]-1H- indazol-3-yl}-5- methoxy-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 18-2 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 2800 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379062 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379062&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71554488 404339049 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757215 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2c(Cl)ccc(C(O)=O)c2Cl)c2ccccc12 InChI=1S/C25H18Cl2N6O3/c1-36-20-12-29-24(31-23(20)30-14-8-10-28-11-9-14)22-15-4-2-3-5-19(15)33(32-22)13-17-18(26)7-6-16(21(17)27)25(34)35/h2-12H,13H2,1H3,(H,34,35)(H,28,29,30,31) ZKJVPIMBAZPGPR-UHFFFAOYSA-N 379063 Preparation of 2,4-dichloro-3-({3-[5-methoxy-4-(pyridin-4-ylamino)pyrimidin-2-yl]-1H-indazol-1-yl}methyl)benzoic acid::US10266548, Example 19-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 20000 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379063 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379063&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71554489 404339050 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757216 CCOc1cc(F)c(Cn2nc(-c3ncc(OCC(O)=O)c(Nc4ccncc4)n3)c3ccccc23)c(F)c1 InChI=1S/C27H22F2N6O4/c1-2-38-17-11-20(28)19(21(29)12-17)14-35-22-6-4-3-5-18(22)25(34-35)27-31-13-23(39-15-24(36)37)26(33-27)32-16-7-9-30-10-8-16/h3-13H,2,14-15H2,1H3,(H,36,37)(H,30,31,32,33) PKXPPDSDTAVNGD-UHFFFAOYSA-N 379064 ({2-[1-(4-ethoxy- 2,6- difluorobenzyl)- 1H-indazol-3-yl]- 4-(pyridin-4- yla- mino)pyrimidin-5- yl}oxy)acetic acid::US10266548, Example 19-2 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 6.30 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379064 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379064&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71554579 404339051 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757217 CNC(=O)c1ccc(Cl)c(Cn2nc(-c3ncc(OC)c(Nc4ccncc4)n3)c3ccccc23)c1Cl InChI=1S/C26H21Cl2N7O2/c1-29-26(36)17-7-8-19(27)18(22(17)28)14-35-20-6-4-3-5-16(20)23(34-35)25-31-13-21(37-2)24(33-25)32-15-9-11-30-12-10-15/h3-13H,14H2,1-2H3,(H,29,36)(H,30,31,32,33) JGDYLAIBSZDBMM-UHFFFAOYSA-N 379065 Preparation of 2,4-dichloro-3-({3-[5-methoxy-4-(pyridin-4-ylamino)pyrimidin-2-yl]-1H-indazol-1-yl}methyl)-N-methylbenzamide::US10266548, Example 20-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 200 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379065 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379065&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71554580 404339052 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757218 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2c(Cl)ccc(C(N)=O)c2Cl)c2ccccc12 InChI=1S/C25H19Cl2N7O2/c1-36-20-12-30-25(32-24(20)31-14-8-10-29-11-9-14)22-15-4-2-3-5-19(15)34(33-22)13-17-18(26)7-6-16(21(17)27)23(28)35/h2-12H,13H2,1H3,(H2,28,35)(H,29,30,31,32) QJPYVEGHAFJSLD-UHFFFAOYSA-N 379066 2,4-dichloro-3- ({3-[5-methoxy-4- (pyridin-4- yla- mino)pyrimidin-2- yl]-1H-indazol-1- yl}methyl) benzamide::US10266548, Example 20-2 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 40.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379066 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379066&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71554582 404339053 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757219 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2c(Cl)ccc(C(=O)N(C)C)c2Cl)c2ccccc12 InChI=1S/C27H23Cl2N7O2/c1-35(2)27(37)18-8-9-20(28)19(23(18)29)15-36-21-7-5-4-6-17(21)24(34-36)26-31-14-22(38-3)25(33-26)32-16-10-12-30-13-11-16/h4-14H,15H2,1-3H3,(H,30,31,32,33) AFORFZICVHNLAQ-UHFFFAOYSA-N 379067 2,4-dichloro-3- ({3-[5-methoxy-4- (pyridin-4- yla- mino)pyrimidin-2- yl]-1H-indazol-1- yl}methyl)-N,N- dimethyl- benzamide::US10266548, Example 20-3 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 1200 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379067 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379067&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71554583 404339054 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757220 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2c(Cl)ccc(C(=O)NCCO)c2Cl)c2ccccc12 InChI=1S/C27H23Cl2N7O3/c1-39-22-14-32-26(34-25(22)33-16-8-10-30-11-9-16)24-17-4-2-3-5-21(17)36(35-24)15-19-20(28)7-6-18(23(19)29)27(38)31-12-13-37/h2-11,14,37H,12-13,15H2,1H3,(H,31,38)(H,30,32,33,34) IDETUTKEHOOTIP-UHFFFAOYSA-N 379068 2,4-dichloro-N-(2- hydroxyethyl)-3- ({3-[5-methoxy-4- (pyridin-4- yla- mino)pyrimidin-2- yl]-1H-indazol-1- yl}methyl) benzamide::US10266548, Example 20-4 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 750 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379068 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379068&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71553266 404339055 C04080 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757221 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2c(Cl)ccc(C(=O)N3CCOCC3)c2Cl)c2ccccc12 InChI=1S/C29H25Cl2N7O3/c1-40-24-16-33-28(35-27(24)34-18-8-10-32-11-9-18)26-19-4-2-3-5-23(19)38(36-26)17-21-22(30)7-6-20(25(21)31)29(39)37-12-14-41-15-13-37/h2-11,16H,12-15,17H2,1H3,(H,32,33,34,35) QIMCTWPUKUXZIH-UHFFFAOYSA-N 379069 US10266548, Example 20-5::[2,4-dichloro-3- ({3-[5-methoxy-4- (pyridin-4- yla- mino)pyrimidin-2- yl]-1H-indazol-1- yl}methyl)phenyl] (morpholin-4- yl)methanone Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 8800 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379069 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379069&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89495306 404339056 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757222 CNC(=O)c1cc(F)c(Cn2nc(-c3ncc(OC)c(Nc4ccncc4)n3)c3ccccc23)c(F)c1 InChI=1S/C26H21F2N7O2/c1-29-26(36)15-11-19(27)18(20(28)12-15)14-35-21-6-4-3-5-17(21)23(34-35)25-31-13-22(37-2)24(33-25)32-16-7-9-30-10-8-16/h3-13H,14H2,1-2H3,(H,29,36)(H,30,31,32,33) OPJKDHGOSCDXRN-UHFFFAOYSA-N 379070 3,5-difluoro-4-({3- [5-methoxy-4- (pyridin-4- yla- mino)pyrimidin-2- yl]-1H-indazol-1- yl}methyl)-N- methylbenzamide::US10266548, Example 20-6 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 6700 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379070 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379070&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 90373599 404339057 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757223 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2ccc(cc2F)C#C)c2ccccc12 InChI=1S/C26H19FN6O/c1-3-17-8-9-18(21(27)14-17)16-33-22-7-5-4-6-20(22)24(32-33)26-29-15-23(34-2)25(31-26)30-19-10-12-28-13-11-19/h1,4-15H,16H2,2H3,(H,28,29,30,31) GQTRSJVMOAJKQQ-UHFFFAOYSA-N 379071 Preparation of 2-[1-(4-ethynyl-2-fluorobenzyl)-1H-indazol-3-yl]-5-methoxy-N-(pyridin-4-yl)pyrimidin-4-amine::US10266548, Example 21-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 28.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379071 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379071&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 86732451 404339058 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757224 OCC1COc2cnc(nc2N1c1ccncc1)-c1nn(Cc2ccccc2F)c2ccccc12 InChI=1S/C26H21FN6O2/c27-21-7-3-1-5-17(21)14-32-22-8-4-2-6-20(22)24(31-32)25-29-13-23-26(30-25)33(19(15-34)16-35-23)18-9-11-28-12-10-18/h1-13,19,34H,14-16H2 ZZKYXGCWQVNBPL-UHFFFAOYSA-N 379072 Preparation of {2-[1-(2-fluorobenzyl)-1H-indazol-3-yl]-8-(pyridin-4-yl)-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-7-yl}methanol::US10266548, Example 22-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 770 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379072 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379072&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 86732452 404339059 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757225 COc1cnc(nc1N(C)c1ccncc1)-c1nn(Cc2ccccc2F)c2ccccc12 InChI=1S/C25H21FN6O/c1-31(18-11-13-27-14-12-18)25-22(33-2)15-28-24(29-25)23-19-8-4-6-10-21(19)32(30-23)16-17-7-3-5-9-20(17)26/h3-15H,16H2,1-2H3 INTSXBYBMYZFJL-UHFFFAOYSA-N 379073 Preparation of 2-[1-(2-fluorobenzyl)-1H-indazol-3-yl]-5-methoxy-N-methyl-N-(pyridin-4-yl)pyrimidin-4-amine::US10266548, Example 23-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 1400 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379073 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379073&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 86732453 404339060 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757226 COc1cnc(nc1Nc1ccncc1C#N)-c1nn(Cc2ccccc2F)c2ccccc12 InChI=1S/C25H18FN7O/c1-34-22-14-29-25(31-24(22)30-20-10-11-28-13-17(20)12-27)23-18-7-3-5-9-21(18)33(32-23)15-16-6-2-4-8-19(16)26/h2-11,13-14H,15H2,1H3,(H,28,29,30,31) KQNUONUIOILLKB-UHFFFAOYSA-N 379074 Preparation of 4-({2-[1-(2-fluorobenzyl)-1H-indazol-3-yl]-5-methoxypyrimidin-4-yl}amino)pyridine-3-carbonitrile::US10266548, Example 24-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 62.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379074 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379074&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 86732454 404339061 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757227 COC(=O)c1cnccc1Nc1nc(ncc1OC)-c1nn(Cc2ccccc2F)c2ccccc12 InChI=1S/C26H21FN6O3/c1-35-22-14-29-25(31-24(22)30-20-11-12-28-13-18(20)26(34)36-2)23-17-8-4-6-10-21(17)33(32-23)15-16-7-3-5-9-19(16)27/h3-14H,15H2,1-2H3,(H,28,29,30,31) BTIVSGFMFHTMTA-UHFFFAOYSA-N 379075 US10266548, Example 24-2::methyl 4-({2-[1- (2-fluorobenzyl)- 1H-indazol-3-yl]- 5- methoxypyrimidin- 4- yl}amino)pyridine- 3-carboxylate Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 20000 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379075 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379075&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89487238 404339062 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757228 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2ccccc2F)c2ccccc12 InChI=1S/C24H19FN6O/c1-32-21-14-27-24(29-23(21)28-17-10-12-26-13-11-17)22-18-7-3-5-9-20(18)31(30-22)15-16-6-2-4-8-19(16)25/h2-14H,15H2,1H3,(H,26,27,28,29) WXZBIHKYDPLPOR-UHFFFAOYSA-N 378930 2-[1-(2- fluorobenzyl)- 1H-indazol-3-yl]- 5-methoxy-N- (pyridin-4- yl)pyrimidin-4- amine::US10266548, Example 2-18-1::US10266548, Example 24-3 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 13.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=378930 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=378930&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71553617 404338924 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757229 COc1cnc(nc1N(c1ccncc1)c1ccncc1)-c1nn(Cc2ccccc2F)c2ccccc12 InChI=1S/C29H22FN7O/c1-38-26-18-33-28(34-29(26)37(21-10-14-31-15-11-21)22-12-16-32-17-13-22)27-23-7-3-5-9-25(23)36(35-27)19-20-6-2-4-8-24(20)30/h2-18H,19H2,1H3 SCNMBJFXAZAYNS-UHFFFAOYSA-N 379077 2-[1-(2- fluorobenzyl)-1H- indazol-3-yl]-5- methoxy-N,N- di(pyridin-4- yl)pyrimidin-4-amine::US10266548, Example 24-4 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 4280 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379077 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379077&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89488581 404339063 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757230 CCOc1cc(F)c(Cn2nc(-c3ncc(OC)c(Nc4ccncc4C#N)n3)c3ccccc23)c(F)c1 InChI=1S/C27H21F2N7O2/c1-3-38-17-10-20(28)19(21(29)11-17)15-36-23-7-5-4-6-18(23)25(35-36)27-32-14-24(37-2)26(34-27)33-22-8-9-31-13-16(22)12-30/h4-11,13-14H,3,15H2,1-2H3,(H,31,32,33,34) OQRNONCZLYNPGJ-UHFFFAOYSA-N 379078 4-({2-[1-(4-ethoxy- 2,6-difluorobenzyl)- 1H-indazol-3-yl]-5- methoxypyrimidin-4- yl}amino)pyridine-3- carbonitrile::US10266548, Example 24-5 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 11.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379078 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379078&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89487388 404339064 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757231 CCOc1cc(O)c(Cn2nc(-c3ncc(OC)c(Nc4cc(C)nc(C)c4)n3)c3ccccc23)c(F)c1 InChI=1S/C28H27FN6O3/c1-5-38-19-12-22(29)21(24(36)13-19)15-35-23-9-7-6-8-20(23)26(34-35)28-30-14-25(37-4)27(33-28)32-18-10-16(2)31-17(3)11-18/h6-14,36H,5,15H2,1-4H3,(H,30,31,32,33) KKHICXAIQOBJIR-UHFFFAOYSA-N 379079 2-[(3-[4-[(2,6- dimethylpyridin-4- yl)amino]-5- methoxypyrimidin-2- yl}-1H-indazol-1- yl)methyl]-5-ethoxy- 3-fluorophenol::US10266548, Example 24-6 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 940 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379079 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379079&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89488589 404339065 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757232 COc1ccc(Cn2nc(-c3ncc(OC)c(Nc4cc[nH]c(=O)c4)n3)c3ccccc23)cc1 InChI=1S/C25H22N6O3/c1-33-18-9-7-16(8-10-18)15-31-20-6-4-3-5-19(20)23(30-31)25-27-14-21(34-2)24(29-25)28-17-11-12-26-22(32)13-17/h3-14H,15H2,1-2H3,(H2,26,27,28,29,32) GJWAVHLXZMTRDC-UHFFFAOYSA-N 379080 4-({5-methoxy-2-[1- (4-methoxybenzyl)- 1H-indazol-3- yl]pyrimidin-4- yl}amino)pyridin- 2(1H)-one::US10266548, Example 24-7 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 1200 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379080 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379080&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 145865861 404339066 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757233 CCOc1cc(F)c(Cn2nc(-c3ncc(OC)c(Nc4cc[nH]c(=O)c4)n3)c3ccccc23)c(F)c1 InChI=1S/C26H22F2N6O3/c1-3-37-16-11-19(27)18(20(28)12-16)14-34-21-7-5-4-6-17(21)24(33-34)26-30-13-22(36-2)25(32-26)31-15-8-9-29-23(35)10-15/h4-13H,3,14H2,1-2H3,(H2,29,30,31,32,35) QNXRAHNLBWGHME-UHFFFAOYSA-N 379081 4-({2-[1-(4-ethoxy- 2,6-difluorobenzyl)- 1H-indazol-3-yl]-5- methoxypyrimidin-4- yl}amino)pyridin- 2(1H)-one::US10266548, Example 24-8 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 26.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379081 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379081&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 145865862 404339067 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757234 COc1cnc(nc1Nc1ccncc1C(N)=O)-c1nn(Cc2ccccc2F)c2ccccc12 InChI=1S/C25H20FN7O2/c1-35-21-13-29-25(31-24(21)30-19-10-11-28-12-17(19)23(27)34)22-16-7-3-5-9-20(16)33(32-22)14-15-6-2-4-8-18(15)26/h2-13H,14H2,1H3,(H2,27,34)(H,28,29,30,31) ITMCKDDCUADICO-UHFFFAOYSA-N 379082 Preparation of 4-({2-[1-(2-fluorobenzyl)-1H-indazol-3-yl]-5-methoxypyrimidin-4-yl}amino)pyridine-3-carboxamide::US10266548, Example 25-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 13.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379082 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379082&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 86732455 404339068 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757235 CCCc1ccc(Cn2nc(-c3ncc(OC)c(Nc4ccncc4C(N)=O)n3)c3ccccc23)cc1 InChI=1S/C28H27N7O2/c1-3-6-18-9-11-19(12-10-18)17-35-23-8-5-4-7-20(23)25(34-35)28-31-16-24(37-2)27(33-28)32-22-13-14-30-15-21(22)26(29)36/h4-5,7-16H,3,6,17H2,1-2H3,(H2,29,36)(H,30,31,32,33) NXOUTCZKYGEGHY-UHFFFAOYSA-N 379083 4-({5-methoxy-2-[1- (4-propylbenzyl)- 1H-indazol-3- yl]pyrimidin-4- yl}amino)pyridine-3- carboxamide::US10266548, Example 25-2 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 5.40 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379083 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379083&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89487514 404339069 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757236 CCOc1cc(F)c(Cn2nc(-c3ncc(OC)c(Nc4ccncc4C(N)=O)n3)c3ccccc23)c(F)c1 InChI=1S/C27H23F2N7O3/c1-3-39-15-10-19(28)18(20(29)11-15)14-36-22-7-5-4-6-16(22)24(35-36)27-32-13-23(38-2)26(34-27)33-21-8-9-31-12-17(21)25(30)37/h4-13H,3,14H2,1-2H3,(H2,30,37)(H,31,32,33,34) KGMZSVKLHPLKJI-UHFFFAOYSA-N 379084 4-({2-[1-(4-ethoxy- 2,6-difluorobenzyl)- 1H-indazol-3-yl]-5- methoxypyrimidin-4- yl}amino)pyridine-3- carboxamide::US10266548, Example 25-3 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 8.80 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379084 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379084&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89487474 404339070 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757237 COc1cnc(nc1Nc1ccncc1C(N)=O)-c1nn(Cc2c(F)cc(O)cc2F)c2ccccc12 InChI=1S/C25H19F2N7O3/c1-37-21-11-30-25(32-24(21)31-19-6-7-29-10-15(19)23(28)36)22-14-4-2-3-5-20(14)34(33-22)12-16-17(26)8-13(35)9-18(16)27/h2-11,35H,12H2,1H3,(H2,28,36)(H,29,30,31,32) IXIKGCUUVXCIBR-UHFFFAOYSA-N 379085 4-({2-[1-(2,6- difluoro-4- hydroxybenzyl)-1H- indazol-3-yl]-5- methoxypyrimidin-4- yl}amino)pyridine-3- carboxamide::US10266548, Example 25-4 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 5.03 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379085 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379085&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89487472 404339071 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757238 Oc1cnc(nc1Nc1ccncc1C#N)-c1nn(Cc2ccccc2F)c2ccccc12 InChI=1S/C24H16FN7O/c25-18-7-3-1-5-15(18)14-32-20-8-4-2-6-17(20)22(31-32)24-28-13-21(33)23(30-24)29-19-9-10-27-12-16(19)11-26/h1-10,12-13,33H,14H2,(H,27,28,29,30) NBDVQFWOWMQCLS-UHFFFAOYSA-N 379086 Preparation of 4-({2-[1-(2-fluorobenzyl)-1H-indazol-3-yl]-5-hydroxypyrimidin-4-yl}amino)pyridine-3-carbonitrile::US10266548, Example 26-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 17.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379086 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379086&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 136341425 404339072 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757239 Fc1ccccc1Cn1nc(-c2ncc(Oc3ccncc3C#N)c(Nc3ccncc3C#N)n2)c2ccccc12 InChI=1S/C30H18FN9O/c31-23-7-3-1-5-19(23)18-40-25-8-4-2-6-22(25)28(39-40)30-36-17-27(41-26-10-12-35-16-21(26)14-33)29(38-30)37-24-9-11-34-15-20(24)13-32/h1-12,15-17H,18H2,(H,34,36,37,38) SWMGTTTWZJNMJL-UHFFFAOYSA-N 379087 4-({4-[(3- cyanopyridin-4- yl)amino]-2-[1-(2- fluorobenzyl)-1H- indazol-3- yl]pyrimidin-5- yl}oxy)pyridine-3- carbonitrile::US10266548, Example 26-2 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 2400 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379087 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379087&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89487807 404339073 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757240 COc1ccc(Cn2nc(-c3ncc(OC)c(Nc4ccncc4C(F)(F)F)n3)c3ccccc23)cc1 InChI=1S/C26H21F3N6O2/c1-36-17-9-7-16(8-10-17)15-35-21-6-4-3-5-18(21)23(34-35)25-31-14-22(37-2)24(33-25)32-20-11-12-30-13-19(20)26(27,28)29/h3-14H,15H2,1-2H3,(H,30,31,32,33) IKYHSKYZLICMDT-UHFFFAOYSA-N 379088 Preparation of 5-methoxy-2-[1-(4-methoxybenzyl)-1H-indazol-3-yl]-N-[3-(trifluoromethyl)pyridin-4-yl]pyrimidin-4-amine::US10266548, Example 27-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 55.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379088 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379088&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 86732457 404339074 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757241 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2ccc(cc2Cl)C(O)=O)c2ccccc12 InChI=1S/C25H19ClN6O3/c1-35-21-13-28-24(30-23(21)29-17-8-10-27-11-9-17)22-18-4-2-3-5-20(18)32(31-22)14-16-7-6-15(25(33)34)12-19(16)26/h2-13H,14H2,1H3,(H,33,34)(H,27,28,29,30) IWWXWULTYJURKP-UHFFFAOYSA-N 379089 Preparation of 3-chloro-4-({3-[5-methoxy-4-(pyridin-4-ylamino)pyrimidin-2-yl]-1H-indazol-1-yl}methyl)benzoic acid::US10266548, Example 28-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 3700 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379089 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379089&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 86732458 404339075 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757242 CNC(=O)c1ccc(Cn2nc(-c3ncc(OC)c(Nc4ccncc4)n3)c3ccccc23)c(Cl)c1 InChI=1S/C26H22ClN7O2/c1-28-26(35)16-7-8-17(20(27)13-16)15-34-21-6-4-3-5-19(21)23(33-34)25-30-14-22(36-2)24(32-25)31-18-9-11-29-12-10-18/h3-14H,15H2,1-2H3,(H,28,35)(H,29,30,31,32) CFVPIQHTHAKGFS-UHFFFAOYSA-N 379090 Preparation of formic acid-3-chloro-4-({3-[5-methoxy-4-(pyridin-4-ylamino)pyrimidin-2-yl]-1H-indazol-1-yl}methyl)-N-methylbenzamide (1:1)::US10266548, Example 29-1::US10266548, Example 29-2 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 11.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379090 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379090&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 86732460 404339076 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757243 CNC(=O)c1ccc(Cn2nc(-c3ncc(OC)c(Nc4ccncc4)n3)c3ccccc23)c(Cl)c1 InChI=1S/C26H22ClN7O2/c1-28-26(35)16-7-8-17(20(27)13-16)15-34-21-6-4-3-5-19(21)23(33-34)25-30-14-22(36-2)24(32-25)31-18-9-11-29-12-10-18/h3-14H,15H2,1-2H3,(H,28,35)(H,29,30,31,32) CFVPIQHTHAKGFS-UHFFFAOYSA-N 379090 Preparation of formic acid-3-chloro-4-({3-[5-methoxy-4-(pyridin-4-ylamino)pyrimidin-2-yl]-1H-indazol-1-yl}methyl)-N-methylbenzamide (1:1)::US10266548, Example 29-1::US10266548, Example 29-2 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 8.90 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379090 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379090&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 86732460 404339076 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757244 NC(=O)c1cnccc1Nc1nc(ncc1O)-c1nn(Cc2ccccc2F)c2ccccc12 InChI=1S/C24H18FN7O2/c25-17-7-3-1-5-14(17)13-32-19-8-4-2-6-15(19)21(31-32)24-28-12-20(33)23(30-24)29-18-9-10-27-11-16(18)22(26)34/h1-12,33H,13H2,(H2,26,34)(H,27,28,29,30) HXZSITACMNXYCR-UHFFFAOYSA-N 379092 Preparation of 4-({2-[1-(2-fluorobenzyl)-1H-indazol-3-yl]-5-hydroxypyrimidin-4-yl}amino)pyridine-3-carboxamide::US10266548, Example 30-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 17.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379092 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379092&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 136341426 404339077 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757245 OC(=O)c1cnccc1Nc1nc(ncc1O)-c1nn(Cc2ccccc2F)c2ccccc12 InChI=1S/C24H17FN6O3/c25-17-7-3-1-5-14(17)13-31-19-8-4-2-6-15(19)21(30-31)23-27-12-20(32)22(29-23)28-18-9-10-26-11-16(18)24(33)34/h1-12,32H,13H2,(H,33,34)(H,26,27,28,29) JYIYPAHELQDICM-UHFFFAOYSA-N 379093 4-({2-[1-(2- fluorobenzyl)-1H- indazol-3-yl]-5- hydroxypyrimidin-4- yl}amino)pyridine-3- carboxylic acid::US10266548, Example 30-2 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 20.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379093 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379093&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 136506165 404339078 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757246 CCOC(=O)c1cnccc1Nc1nc(ncc1O)-c1nn(Cc2ccccc2F)c2ccccc12 InChI=1S/C26H21FN6O3/c1-2-36-26(35)18-13-28-12-11-20(18)30-24-22(34)14-29-25(31-24)23-17-8-4-6-10-21(17)33(32-23)15-16-7-3-5-9-19(16)27/h3-14,34H,2,15H2,1H3,(H,28,29,30,31) ZYCUGTRKRLZPCA-UHFFFAOYSA-N 379094 US10266548, Example 30-3::ethyl 4-({2-[1-(2- fluorobenzyl)-1H- indazol-3-yl]-5- hydroxypyrimidin-4- yl}amino)pyridine-3- carboxylate Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 8.40 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379094 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379094&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 136506167 404339079 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757247 Fc1ccccc1Cn1nc(-c2ncc(C#N)c(Nc3ccncc3)n2)c2ccccc12 InChI=1S/C24H16FN7/c25-20-7-3-1-5-16(20)15-32-21-8-4-2-6-19(21)22(31-32)24-28-14-17(13-26)23(30-24)29-18-9-11-27-12-10-18/h1-12,14H,15H2,(H,27,28,29,30) NFHVGWMVOALSQI-UHFFFAOYSA-N 379095 Preparation of 2-[1-(2-fluorobenzyl)-1H-indazol-3-yl]-4-(pyridin-4-ylamino)pyrimidine-5-carbonitrile::US10266548, Example 31-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 4700 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379095 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379095&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 86732462 404339080 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757248 NC(=O)c1cnc(nc1Nc1ccncc1)-c1nn(Cc2ccccc2F)c2ccccc12 InChI=1S/C24H18FN7O/c25-19-7-3-1-5-15(19)14-32-20-8-4-2-6-17(20)21(31-32)24-28-13-18(22(26)33)23(30-24)29-16-9-11-27-12-10-16/h1-13H,14H2,(H2,26,33)(H,27,28,29,30) KXIVWDXHLRBPAW-UHFFFAOYSA-N 379096 Preparation of 2-[1-(2-fluorobenzyl)-1H-indazol-3-yl]-4-(pyridin-4-ylamino)pyrimidine-5-carboxamide::US10266548, Example 32-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 120 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379096 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379096&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 86732463 404339081 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757249 OCCOc1cnc(nc1Nc1ccncc1C(O)=O)-c1nn(Cc2ccccc2F)c2ccccc12 InChI=1S/C26H21FN6O4/c27-19-7-3-1-5-16(19)15-33-21-8-4-2-6-17(21)23(32-33)25-29-14-22(37-12-11-34)24(31-25)30-20-9-10-28-13-18(20)26(35)36/h1-10,13-14,34H,11-12,15H2,(H,35,36)(H,28,29,30,31) IZUHWUPJKRWDNZ-UHFFFAOYSA-N 379097 Preparation of 4-({2-[1-(2-fluorobenzyl)-1H-indazol-3-yl]-5-(2-hydroxyethoxy)pyrimidin-4-yl}amino)pyridine-3-carboxylic acid hydrochloride (1:1)::US10266548, Example 33-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 11.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379097 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379097&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 86732465 404339082 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757250 COc1ccc(Cn2nc(-c3ncc(OC)c(Nc4ccnc(F)c4)n3)c3ccccc23)cc1 InChI=1S/C25H21FN6O2/c1-33-18-9-7-16(8-10-18)15-32-20-6-4-3-5-19(20)23(31-32)25-28-14-21(34-2)24(30-25)29-17-11-12-27-22(26)13-17/h3-14H,15H2,1-2H3,(H,27,28,29,30) GQGDUAXCIVOMMO-UHFFFAOYSA-N 379098 Preparation of N-(2-fluoropyridin-4-yl)-5-methoxy-2-[1-(4-methoxybenzyl)-1H-indazol-3-yl]pyrimidin-4-amine::US10266548, Example 34-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 230 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379098 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379098&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 86732467 404339083 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757251 COc1ccc(Cn2nc(-c3ncc(OC)c(Nc4cc(F)nc(F)c4)n3)c3ccccc23)cc1 InChI=1S/C25H20F2N6O2/c1-34-17-9-7-15(8-10-17)14-33-19-6-4-3-5-18(19)23(32-33)25-28-13-20(35-2)24(31-25)29-16-11-21(26)30-22(27)12-16/h3-13H,14H2,1-2H3,(H,28,29,30,31) HPFLSYTXZVPERW-UHFFFAOYSA-N 379099 N-(2,6- difluoropyridin-4-yl)- 5-methoxy-2-[1-(4- methoxybenzyl)-1H- indazol-3- yl]pyrimidin-4-amine::US10266548, Example 34-2 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 6200 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379099 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379099&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71554486 404339084 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757252 COc1ccc(Cn2nc(-c3ncc(OC)c(Nc4ccncc4F)n3)c3ccccc23)cc1 InChI=1S/C25H21FN6O2/c1-33-17-9-7-16(8-10-17)15-32-21-6-4-3-5-18(21)23(31-32)25-28-14-22(34-2)24(30-25)29-20-11-12-27-13-19(20)26/h3-14H,15H2,1-2H3,(H,27,28,29,30) RFHZHDSRRLVHGU-UHFFFAOYSA-N 379100 N-(3-fluoropyridin-4- yl)-5-methoxy-2-[1- (4-methoxybenzyl)- 1H-indazol-3- yl]pyrimidin-4-amine::US10266548, Example 34-3 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 28.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379100 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379100&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71554485 404339085 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757253 COc1ccc(Cn2nc(-c3ncc(OC)c(Nc4ccnc(C)c4)n3)c3ccccc23)cc1 InChI=1S/C26H24N6O2/c1-17-14-19(12-13-27-17)29-25-23(34-3)15-28-26(30-25)24-21-6-4-5-7-22(21)32(31-24)16-18-8-10-20(33-2)11-9-18/h4-15H,16H2,1-3H3,(H,27,28,29,30) UFDXZDRGPGMOCA-UHFFFAOYSA-N 379101 5-methoxy-2-[1-(4- methoxybenzyl)-1H- indazol-3-yl)-N-(2- methylpyridin-4- yl)pyrimidin-4-amine::US10266548, Example 34-4 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 120 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379101 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379101&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71554406 404339086 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757254 CCOc1cc(F)c(Cn2nc(-c3nccc(n3)N(C(F)F)c3ccncc3)c3ccccc23)c(F)c1 InChI=1S/C26H20F4N6O/c1-2-37-17-13-20(27)19(21(28)14-17)15-35-22-6-4-3-5-18(22)24(34-35)25-32-12-9-23(33-25)36(26(29)30)16-7-10-31-11-8-16/h3-14,26H,2,15H2,1H3 OTQAYWVPAQNBOV-UHFFFAOYSA-N 379102 Preparation of N-(difluoromethyl)-2-[1-(4-ethoxy-2,6-difluorobenzyl)-1H-indazol-3-yl]-N-(pyridin-4-yl)pyrimidin-4-amine::US10266548, Example 35-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 1300 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379102 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379102&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71554405 404339087 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757255 CCOc1cc(F)c(Cn2nc(-c3ncc(OCCS(C)=O)c(Nc4ccncc4)n3)c3ccccc23)c(F)c1 InChI=1S/C28H26F2N6O3S/c1-3-38-19-14-22(29)21(23(30)15-19)17-36-24-7-5-4-6-20(24)26(35-36)28-32-16-25(39-12-13-40(2)37)27(34-28)33-18-8-10-31-11-9-18/h4-11,14-16H,3,12-13,17H2,1-2H3,(H,31,32,33,34) SNCZUOCGGAOFIY-UHFFFAOYSA-N 379103 Preparation of 2-[1-(4-ethoxy-2,6-difluorobenzyl)-1H-indazol-3-yl]-5-[2-(methylsulfinyl)ethoxy]-N-(pyridin-4-yl)pyrimidin-4-amine::US10266548, Example 36-1::US10266548, Example 36-2::US10266548, Example 36-3 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 4.91 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379103 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379103&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71554404 404339088 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757256 CCOc1cc(F)c(Cn2nc(-c3ncc(OCCS(C)=O)c(Nc4ccncc4)n3)c3ccccc23)c(F)c1 InChI=1S/C28H26F2N6O3S/c1-3-38-19-14-22(29)21(23(30)15-19)17-36-24-7-5-4-6-20(24)26(35-36)28-32-16-25(39-12-13-40(2)37)27(34-28)33-18-8-10-31-11-9-18/h4-11,14-16H,3,12-13,17H2,1-2H3,(H,31,32,33,34) SNCZUOCGGAOFIY-UHFFFAOYSA-N 379103 Preparation of 2-[1-(4-ethoxy-2,6-difluorobenzyl)-1H-indazol-3-yl]-5-[2-(methylsulfinyl)ethoxy]-N-(pyridin-4-yl)pyrimidin-4-amine::US10266548, Example 36-1::US10266548, Example 36-2::US10266548, Example 36-3 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 6.20 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379103 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379103&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71554404 404339088 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757257 CCOc1cc(F)c(Cn2nc(-c3ncc(OCCS(C)=O)c(Nc4ccncc4)n3)c3ccccc23)c(F)c1 InChI=1S/C28H26F2N6O3S/c1-3-38-19-14-22(29)21(23(30)15-19)17-36-24-7-5-4-6-20(24)26(35-36)28-32-16-25(39-12-13-40(2)37)27(34-28)33-18-8-10-31-11-9-18/h4-11,14-16H,3,12-13,17H2,1-2H3,(H,31,32,33,34) SNCZUOCGGAOFIY-UHFFFAOYSA-N 379103 Preparation of 2-[1-(4-ethoxy-2,6-difluorobenzyl)-1H-indazol-3-yl]-5-[2-(methylsulfinyl)ethoxy]-N-(pyridin-4-yl)pyrimidin-4-amine::US10266548, Example 36-1::US10266548, Example 36-2::US10266548, Example 36-3 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 6.30 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379103 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379103&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71554404 404339088 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757258 CCOc1cc(F)c(Cn2nc(-c3ncc(OCCS(C)(=O)=O)c(Nc4ccncc4)n3)c3ccccc23)c(F)c1 InChI=1S/C28H26F2N6O4S/c1-3-39-19-14-22(29)21(23(30)15-19)17-36-24-7-5-4-6-20(24)26(35-36)28-32-16-25(40-12-13-41(2,37)38)27(34-28)33-18-8-10-31-11-9-18/h4-11,14-16H,3,12-13,17H2,1-2H3,(H,31,32,33,34) JEAATUWLUGSQCU-UHFFFAOYSA-N 379106 Preparation of 2-[1-(4-ethoxy-2,6-difluorobenzyl)-1H-indazol-3-yl]-5-[2-(methylsulfonyl)ethoxy]-N-(pyridin-4-yl)pyrimidin-4-amine::US10266548, Example 37-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 5.70 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379106 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379106&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71554403 404339089 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757259 CCOc1cc(F)c(Cn2nc(-c3ncc(OCCN)c(Nc4ccncc4)n3)c3ccccc23)c(F)c1 InChI=1S/C27H25F2N7O2/c1-2-37-18-13-21(28)20(22(29)14-18)16-36-23-6-4-3-5-19(23)25(35-36)27-32-15-24(38-12-9-30)26(34-27)33-17-7-10-31-11-8-17/h3-8,10-11,13-15H,2,9,12,16,30H2,1H3,(H,31,32,33,34) WIZMQSUYMAPRIN-UHFFFAOYSA-N 379107 Preparation of 5-(2-aminoethoxy)-2-[1-(4-ethoxy-2,6-difluorobenzyl)-1H-indazol-3-yl]-N-(pyridin-4-yl)pyrimidin-4-amine::US10266548, Example 38-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 3.40 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379107 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379107&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71540875 404339090 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757260 CCOc1cc(F)c(Cn2nc(-c3ncc(OCC4CNCCO4)c(Nc4ccncc4)n3)c3ccccc23)c(F)c1 InChI=1S/C30H29F2N7O3/c1-2-40-20-13-24(31)23(25(32)14-20)17-39-26-6-4-3-5-22(26)28(38-39)30-35-16-27(42-18-21-15-34-11-12-41-21)29(37-30)36-19-7-9-33-10-8-19/h3-10,13-14,16,21,34H,2,11-12,15,17-18H2,1H3,(H,33,35,36,37) SSQDOCLBEPUOEB-UHFFFAOYSA-N 379108 2-[1-(4-ethoxy-2,6- difluorobenzyl)-1H- indazol-3-yl]-5- (morpholin-2- ylmethoxy)-N- (pyridin-4- yl)pyrimidin-4-amine::US10266548, Example 38-2 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 3.40 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379108 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379108&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 71554402 404339091 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757261 CCOc1cc(F)c(Cn2nc(-c3ncc(OC)c(Nc4c(F)cncc4F)n3)c3ccccc23)c(F)c1 InChI=1S/C26H20F4N6O2/c1-3-38-14-8-17(27)16(18(28)9-14)13-36-21-7-5-4-6-15(21)23(35-36)26-32-12-22(37-2)25(34-26)33-24-19(29)10-31-11-20(24)30/h4-12H,3,13H2,1-2H3,(H,31,32,33,34) XQDVFFCZSILLSE-UHFFFAOYSA-N 379109 N-(3,5- difluoropyridin-4-yl)- 2-[1-(4-ethoxy-2,6- difluorobenzyl)-1H- indazol-3-yl]-5- methoxypyrimidin-4- amine::US10266548, Example 39-2 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 670 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379109 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379109&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 89495364 404339092 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757262 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2c(Cl)ccc(N)c2Cl)c2ccccc12 InChI=1S/C24H19Cl2N7O/c1-34-20-12-29-24(31-23(20)30-14-8-10-28-11-9-14)22-15-4-2-3-5-19(15)33(32-22)13-16-17(25)6-7-18(27)21(16)26/h2-12H,13,27H2,1H3,(H,28,29,30,31) KWGGXMDXSDWBCE-UHFFFAOYSA-N 379110 Preparation of 2-[1-(3-amino-2,6-dichlorobenzyl)-1H-indazol-3-yl]-5-methoxy-N-(pyridin-4-yl)pyrimidin-4-amine::US10266548, Example 40-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 39.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379110 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379110&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 86732472 404339093 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757263 COc1cnc(nc1Nc1ccncc1)-c1nn(Cc2c(Cl)ccc(NC(C)=O)c2Cl)c2ccccc12 InChI=1S/C26H21Cl2N7O2/c1-15(36)31-20-8-7-19(27)18(23(20)28)14-35-21-6-4-3-5-17(21)24(34-35)26-30-13-22(37-2)25(33-26)32-16-9-11-29-12-10-16/h3-13H,14H2,1-2H3,(H,31,36)(H,29,30,32,33) DQCOTHCHPYCPCR-UHFFFAOYSA-N 379111 Preparation of N-[2,4-dichloro-3-({3-[5-methoxy-4-(pyridin-4-ylamino)pyrimidin-2-yl]-1H-indazol-1-yl}methyl)phenyl]acetamide::US10266548, Example 41-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 19.0 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379111 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379111&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 86732473 404339094 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4 757264 CCOc1cc(F)c(Cn2nc(-c3ncc(OC)c(Nc4ccncc4)n3)c3c(C)cccc23)c(F)c1 InChI=1S/C27H24F2N6O2/c1-4-37-18-12-20(28)19(21(29)13-18)15-35-22-7-5-6-16(2)24(22)25(34-35)27-31-14-23(36-3)26(33-27)32-17-8-10-30-11-9-17/h5-14H,4,15H2,1-3H3,(H,30,31,32,33) FNIJBCDZFJFZPU-UHFFFAOYSA-N 379112 Preparation of 2-[1-(4-ethoxy-2,6-difluorobenzyl)-4-methyl-1H-indazol-3-yl]-5-methoxy-N-(pyridin-4-yl)pyrimidin-4-amine::US10266548, Example 42-1 Mitotic checkpoint serine/threonine-protein kinase BUB1 Homo sapiens 6.70 US Patent 10.7270/Q2RV0R1M aid1798408 US10266548 Hitchcock, M; Mengel, A; Putter, V; Siemeister, G; Wengner, AM; Briem, H; Eis, K; Schulze, V; Fernandez-Montalvan, AE; Prechtl, S; Holton, S; Fanghanel, J; Lienau, P; Preusse, C; Gnoth, MJ 4/23/2019 2/7/2020 Bayer Intellectual Property GmbH http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=379112 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50004757&target=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=379112&enzyme=Mitotic+checkpoint+serine%2Fthreonine-protein+kinase+BUB1&column=ki&startPg=0&Increment=50&submit=Search 86732474 404339095 1 MDTPENVLQMLEAHMQSYKGNDPLGEWERYIQWVEENFPENKEYLITLLEHLMKEFLDKKKYHNDPRFISYCLKFAEYNSDLHQFFEFLYNHGIGTLSSPLYIAWAGHLEAQGELQHASAVLQRGIQNQAEPREFLQQQYRLFQTRLTETHLPAQARTSEPLHNVQVLNQMITSKSNPGNNMACISKNQGSELSGVISSACDKESNMERRVITISKSEYSVHSSLASKVDVEQVVMYCKEKLIRGESEFSFEELRAQKYNQRRKHEQWVNEDRHYMKRKEANAFEEQLLKQKMDELHKKLHQVVETSHEDLPASQERSEVNPARMGPSVGSQQELRAPCLPVTYQQTPVNMEKNPREAPPVVPPLANAISAALVSPATSQSIAPPVPLKAQTVTDSMFAVASKDAGCVNKSTHEFKPQSGAEIKEGCETHKVANTSSFHTTPNTSLGMVQATPSKVQPSPTVHTKEALGFIMNMFQAPTLPDISDDKDEWQSLDQNEDAFEAQFQKNVRSSGAWGVNKIISSLSSAFHVFEDGNKENYGLPQPKNKPTGARTFGERSVSRLPSKPKEEVPHAEEFLDDSTVWGIRCNKTLAPSPKSPGDFTSAAQLASTPFHKLPVESVHILEDKENVVAKQCTQATLDSCEENMVVPSRDGKFSPIQEKSPKQALSSHMYSASLLRLSQPAAGGVLTCEAELGVEACRLTDTDAAIAEDPPDAIAGLQAEWMQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSRK 2LAH,4A1G,4R8Q,6F7B Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1_HUMAN O43683 E9PC26 F5GXI5 O43430 O43643 O60626 Q53QE4